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ABSTRACT 
OXIDATIVE FOLDING OF A CYSTINE KNOT PROTEIN: 
THE AMARANTHUS a-AMYLASE INHIBITOR 
Masa Cemazar 
The work described in this thesis is concerned with the study of the oxidative folding 
pathway of a cystine knot protein, Amaranthus a-amylase inhibitor (AAI). The data presented 
in the thesis are obtained with a combination of different biochemical and biophysical tech-
niques, with an emphasis on NMR spectroscopy. 
Chapter 1 gives a short introduction to the structural and functional superfamilies of 
the protein in question. Additionally, it outlines the protein folding problem, with an emphasis 
on oxidative folding, and stresses the importance of studying such pathways in small proteins. 
Chapter 2 covers both the basis of experimental techniques and the details of experimental 
methods used in the study. The remaining four chapters (3, 4, 5 and 6) are results and discussion 
chapters. Each one deals with a specific aspect of the study of the oxidative folding pathway 
of Amaranthus a-amylase inhibitor. 
Chapter 3 presents the results from an improved solid phase peptide synthesis approach, 
which increased the overall yield of peptide synthesis and recovered a greater amount of AAI 
after the refolding step. In Chapter 4 the intermediate species that appear on the oxidative fold-
ing pathway are identified and characterised in terms of their disulfide content. An illustration 
of the structural features of the main folding intermediate (MFI) with NMR, photo-CID NP and 
computer modelling techniques is given in Chapter 5. In Chapter 6 the kinetic process of the 
oxidative folding of Amaranthus a-amylase inhibitor is studied at the level of a single disulfide 
species and at the level of a single amino acid residue. 
The novelty of this thesis is two-fold. First, from the point of view of biological inter-
est, this is the first time that oxidative folding intermediates with non-native disulfide bridges 
between adjacent cysteine residues are observed. Second, from the point of view of develop-
ment of biophysical methods, the first application of time-resolved NMR and photo-CIDNP 
spectroscopy to a complete oxidative folding process is described. 
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Chapter 1 
Introduction 
1.1 Amaranthus a-amylase inhibitor 
The structure and function of a protein are like the genome and personality of a hu-
man being. The similarities of the structural and functional features to other proteins 
produce two fundamental classifications of a protein. The first classification relates 
the features of the protein's three-dimensional fold to other protein structures, whereas 
the second classification focusses on the biological activities and their similarities to 
other activities found in nature. However, neither of these classifications depends on 
the folding process, which converts the amino acid sequence into a specific fold. This 
is because protein folding is still relatively poorly understood and can not be a valid 
criterion in protein classification. 
This thesis is concerned with the oxidative folding process of A maranthus a-
amylase inhibitor (AAI), which belongs to the cystine knot superfamily and to the 
plant inhibitors of insect a-amylase enzymes. In this chapter, a short introduction is 
given to the structural and functional super:families of the protein. Additionally, the 
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protein folding problem, with an emphasis on oxidative folding, is outlined with the 
historical developments that led to its current understanding. The prime reason for 
wanting to understand the structure and folding of AAI and other inhibitor cystine 
knots is their potential as scaffolds for bio-engineered pharmaceutical substances. A 
detailed picture of the oxidative process of AAI can give an example for studies of other 
pharmaceutically relevant cystine knot proteins. 
1.1.1 The cystine knot motif 
The cystine knot is an intriguing structural motif with an embedded ring made up of 
two disulfide bridges and their connecting backbone segments, penetrated by a third 
disulfide bond [1] (Figure 1.1). The scientific interest in cystine knots is probably 
owed both to their widespread distribution across organisms in nature (plants, insects, 
mammals) and to their extreme functional versatility that spreads from enzymes to 
ion channel inhibitors. The fact that these proteins fulfill a large variety of biological 
functions could lead to a conclusion that they have developed via a convergent evo-
lution [2]. In other words, the evolutionary acquisition of similar structural features 
in unrelated proteins is a result of similar adaptations, rather than a common ances-
tor. The cystine knot is also a motif that provides a very high degree of stability to 
molecules that contain it and has been therefore considered as a suitable framework for 
protein engineering applications. 
The term "cystine knot" was first introduced in reviews in 1993 [3, 4] comparing 
the structural similarities between recently determined structures of proteins belonging 
to the growth hormone family. However, throughout the early 1990's numerous pro-
tein structures were being published from other protein families containing the same 
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Figure 1.1: Stereo-view of the cystine knot topology in the Amaranthus a-amylase 
inhibitor molecule.- The two disulfide bridges (I-IV, 11-V) building a ring with their connecting 
backbone segments are coloured in red and the disulfide bridge (III-VI) that is penetrating the 
ring is shown in green. 
structural motif, for example the disulfide rich trypsin inhibitors, cone snail toxins and 
even cystine knots with a circular protein backbone. This is the reason that the cystine 
knot superfamily was first divided into inhibitor cystine knots (ICK) and growth factor 
cystine knots (GFCK) [5, 6] and later an additional subfamily was added featuring 
proteins with a circular backbone [7], the cyclic cystine knots ( CCK), present mainly in 
plant cyclotides. Numerous reviews have dealt with characterisation and classification 
of cystine knots [8, 9, 10, 11, 1]. 
The three cystine knot families share the same disulfide connectivity, which is 
usually referred to as the abc abc topology. This means that the first cysteine in 
protein sequence forms a disulfide bridge with the fourth (I-IV), the second with the 
fifth (II-V) and the third with the sixth cysteine (III-VI). The loop regions of the 
topological knot are remarkably conserved across the three families, which perhaps 
indicates the significance of the loop size for the stability of the fold. However, G FCKs 
have two distinguishable features from ICKs and CCKs: their bigger protein size and 
the disulfide bond which penetrates the embedded ring structure is (I-IV) instead of 
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(III-VI) in ICKs and CCKs. 
The Amaranthus a-amylase inhibitor belongs to the inhibitor family of cys-
tine knots along with other enzyme inhibitors, ion channel blockers and various toxin 
molecules. The inhibitor family, and partially also the other two families of cystine 
knots, have in addition to the I-IV, II-V, III-VI disulfide connectivity also consensus 
spacings between cysteine residues as can be seen in Figure 1.2 [1, 5, 11). Other fea-
tures of the ICK motif are a triple stranded anti-parallel ,8-sheet and several hydrogen 
bonding patterns. A summary of this motif is seen in Figure 1.2. 
Loop3 
----1 n=0-7 
Figure 1.2: Consensus features of the inhibitor cystine knot motif: the cysteine 
residues are labelled I-VI, the intra-cysteine loops 1-5 and the number of intra-cysteine residues 
is n. The black arrows represent hydrogen bonds from the amide proton to the carbonyl group. 
As in Figure 1.1 the two disulfide bridges building a ring are shown in red and the third disulfide 
penetrating the ring is green. Adapted from a recent review by Craik et al [1]. 
The synthesis and folding of the inhibitor family of cystine knots have been 
extensively studied. The common features of the in vitro folding process that are 
displayed after successful solid phase peptide synthesis are the heterogeneous folding 
pathways and the presence of non-native like disulfide intermediates. One extremely 
important species for drug application in pain therapy, the conotoxin MVIIA [12), has 
shown that there is little or no preferential formation of native interactions until two 
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disulfides have formed. 
On the other hand it is worth mentioning that there are two properties of cystine 
knots which make them promising molecules for drug design: exceptional stability and 
well-defined scaffolds. Most of the exciting applications of these proteins have been 
noted in pain therapy (MVIIA and related conotoxins specifically block ion channels 
involved in the transmission of pain), anti-bacterial activity (cyclotide peptides such 
as kalata Bl, circulin A and B) and anti-viral agents (anti-HIV activity of cyclotides). 
However, there still remains plenty of room for developments in molecular bioengineer-
ing approaches. 
1.1.2 a-Amylases and their inhibitors 
The fact that only a limited number of organisms is able to feed on a given plant, 
proves that in plants, mechanisms against insect predation have developed through 
the evolution process. The defence compounds that provide the resistance of plants to 
insects can be either aproteic (antibiotics, alkaloids, terpenes, cyanogenic glucosides) 
or proteic ( chitinases, ,B-1,3-glucanases, lectins, arcelins, vicilins, systemins and en-
zyme inhibitors) [13]. The enzyme inhibitors group provide a protective action against 
digestive hydrolases, proteinases and a-amylases. 
Enzymes belonging to the a-amylase family are multidomain hydrolases and 
transferases with a catalytic domain in the form of a (,B/a)8-barrel [15]. Although 
they are structurally and functionally related proteins, they have been separated into 
three families (13, 70, 77) of glycoside hydrolases according to the amino acid se-
quence similarity. Their function is to catalyse the hydrolysis or transglycosylation of 
a-glucan linkages in starch components, glycogen and other carbohydrates [13, 15]. 
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B c 
Figure 1.3: Tenebrio molitor a-amylase: the three distinctive domains A, B and C are 
coloured in red, green and blue, respectively. The major structural subunit is the A domain, 
which has the form of a (,8/a)8 -barrel and contains the catalytic site and the ligand binding 
residues. The figure was made using ltmq file from the Protein Data Bank with MolMol 
programme [14]. 
The true a-amylases, however, act only on a-1,4-glucosidic linkages (a-1,4-glucan-4-
glucanohydrolases, Enzyme Commission number 3.2.1.1). Generally they are endo-
enzymes, but there exist exceptions with exo-activity, which is likely to be coming from 
the differences in the amino acid sequence of the glucose binding regions. Contrary to 
the exo-a-amylases, their endo-equivalents are able to catalyse more than one glucosidic 
bond breakage during a single enzyme-substrate encounter. They also have a prefer-
ential action near the chain ends and hence produce a greater proportion of certain 
oligosaccharides over others. 
a-Amylases regulate the carbohydrate metabolism in microorganisms, plants and 
animals. In insects, these enzymes are essential for the survival of several species that 
feed on starchy seeds during their larval and adult stages. Although several sequences 
have been characterized, the only determined 3D structure of an insect a-amylase is 
that of the Tenebrio molitor enzyme (TMA) [16], represented in Figure 1.3. Domain A 
of TMA is a characteristic (,B/a)s-barrel and contains the catalytic site and the ligand 
1.1. Amaranthus a-amylase inhibitor 7 
binding residues. Furthermore, a distinctive calcium ion resides in the cavity between 
the catalytic domain A and the globular domain B. This feature is conserved among 
many a-amylases. 
The proteinaceous inhibitors of a-amylases can be classified according to their 
tertiary structure into six classes: lectin-like, thaumatin-like, cereal-type, Kunitz-like, 
1-purothionin-like and knottin-like (13, 17]. The structures and mechanisms of inhi-
bition of the latter four types of inhibitors have been elucidated by resolving the 3D 
structures of the complexes between the inhibitors and the enzymes. In the cases of 
lectin-type, knottin-type and cereal-type inhibitors, the enzyme function is inhibited 
directly through blockage of the catalytic site, whereas the Kunitz-type inhibitors pre-
vent substrate binding through interaction with both A and B domains of the enzymes 
near the catalytic site, but not directly with the catalytic residues. The interaction 
of thaumatin-like and 1-purothionin-like inhibitors with a-amylases has not yet been 
characterized, although some structures of inhibitors belonging to these two classes 
have been determined. Different inhibitors, however, have different specificities towards 
a-amylases from different sources, some for example are insect-specific and inactive to-
wards their mammalian analogues. Including these kind of insect-specific inhibitors in 
transgenic plant approaches could provide inherent protection against insect pests. 
1.1.3 The inhibitor from Amaranthus hypocondriacus seeds 
The smallest known a-amylase inhibitor is found in the seeds of Amaranthus hypocon-
driacus, a variety of the Mexican crop plant Amaranth or Prince's feather. Although 
there are other species in Amaranthus plants that confer inhibitory activity, Amaran-
thus a-amylase inhibitor (AAI) accounts for more than half of the activity in crude seed 
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extract. The most important feature of its activity is that it is species specific as it 
inhibits only a-amylase from insect larvae ( Tribolium castaneum, Prostaphanus trunca-
tus, Periplaneta americana and Tenebrio molitor), but not the mammalian equivalents. 
The structure, function and enzyme binding activity of this inhibitor has been exten-
sively studied. 
I I I I I I 
CIPKWNRCGPKMDGVPCCEPITCTSDYYGNCS 
Figure 1.4: Amaranthus a-amylase inhibitor (AAI): The cysteine rich amino acid-
sequence is shown with the six cysteine residues written in red. The disulfide bridge connectivity 
with the abc abc pattern is shown. 
AAI was first isolated by Chagolla-Lopez et al [18] in 1994, when they determined 
its primary structure, disulfide bridges and built a three-dimensional model based on 
the common structural features of the inhibitor cystine knots. In 1997 a successful 
solid-phase peptide synthesis was reported [19], together with an in vitro oxidative 
refolding protocol. It was confirmed that the refolded synthetic peptide had identi-
cal biological and inhibitory properties as the natural product. The next steps were 
the three-dimensional structure determinations of both the free inhibitor in solution 
by NMR and of the complex with the enzyme by X-ray crystallography, which were 
both published in 1999 [20, 21]. An additional NMR structure of the free inhibitor 
with a comparison to the already published structure came out in 2001 [22]. A more 
detailed structural analysis of the three-dimensional structures and a classification of 
Amaranthus inhibitor within the knottin fold superfamily [2] followed in the same year. 
The overall structure of this small 32-amino acid peptide, the three antiparallel 
/)-strands and the typical abc abc connectivity of disulfides identify it as a member of 
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the inhibitor cystine knots (ICK) [20, 21, 2]. Among proteins in the Protein Data Bank 
that contain abc abc disulfide topology, AAI can be clustered together with 15 other 
proteins that have a high praline content and many of them contain a cis-proline [2]. 
The primary sequence of AAI (Figure 1.4) is strikingly different from other members of 
the ICK family, yet it maintains an almost identical scaffold. Similarly, the members 
of this family show few similarities in surface electrostatics and functionally important 
residues, which strengthens the theory about their convergent evolution [2). 
When AAI binds to the enzyme, two important alterations can be seen in its 3D 
scaffold [2), which can be seen in its unaltered state in Figure 1.5. First, it becomes 
much more compact and hence decreases the solvent accessible surface area and its 
volume. Secondly, residue Pro20 undergoes a trans to cis isomerisation. AAI inserts 
perfectly into the active site of TMA ( Tenebrio molitor a-amylase [21 ], Figure 1.3), 
which is situated at the interface between domains A and B. The complex sees a high 
complementarity of the interacting surfaces, since AAI provides a lid-like surface to the 
deep cleft of the active site in TMA. Upon binding, TMA undergoes a dramatic change 
in the backbone segment of the active site, shortening the helical segment from His286 
to Gly292 by three residues at its C terminus. 
Figure 1.5: Three-dimensional structure of AAI protein: these six images are made 
with MolMol [14] programme, using lqjd file from the Protein Data Bank. Each consecutive 
image of the 3D AAI structure is rotated by 60° anti-clockwise around the vertical axis. 
The next question to ask once a 3D structure of a protein has been determined 
is how the protein folds to this unique, low energy state. Why does this particular 
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sequence encode the specific structure with a particular function? What kind of in-
termediate species appear on the folding pathway as the molecule goes from a linear 
amino acid chain to a globular fold? It is important to determine how separate parts 
of the molecules are stabilised and when in the folding process the various native-like 
contacts and native like-interactions are made. The answers to these questions give 
information that is essential for redesigning molecules with bioengineering approaches. 
1.2 Protein folding 
1.2.1 The protein-folding problem(s) 
After the synthesis of proteins, which come off the ribosome as linear chains of amino 
acids, they need to acquire the 3D structure of the specific function for which they 
have evolved. The process of attaining the unique fold is called protein folding. The 
detailed understanding of this process remains a challenge for two reasons: the secret 
code entails both the 3D fold and the ability to attain it. 
The first problem with protein folding will be solved if we can predict how an 
amino acid sequence encodes a certain 3D array and hence a specific function. This is 
the subject of intense theoretical and experimental strategies. It has become clear that 
the interactions between the side-chains that constitute the 3D fold are not random. 
The key feature that makes a protein functional, resistant to aggregation and degra-
dation, is the high packing of the side chain atoms. In order to help the advancements 
for prediction of this kind of packing, various networks have been established, among 
them probably most prominent the so-called CASP (Critical Assessment of techniques 
for protein Structure Prediction) [23]. The first CASP experiment was run in 1994 
and it consisted of three parts: the collection of targets for prediction from the exper-
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imental community, the collection of predictions from the modelling community, and 
the assessment and discussion of the results. 
The second problem with protein folding is concerned with the proceedings of the 
actual kinetics and dynamics of the process. If we assume that the essential concept in 
protein folding is a random unbiased search, all conformations that a polypetide can 
assume should be equally probable. Therefore the time taken for the protein to find 
the native conformation should be the number of conformations available (say, 1070 
for a 100-residue protein) times the time taken to find one conformation (say, 10-11 
seconds), which leads to an enormous time of folding: about 1052 years. We know that 
most single domain proteins are able to fold in vitro to their native folds within a second, 
but many lie in the mili- or micro-second range. There seems to be a contradiction, 
which is known in the literature as the Levinthal's paradox, introduced in 1968 [24]. 
There is, however, an obvious flaw in Levinthal's analysis, because it assumed that the 
search is unbiased with no stabilisation of any particular conformation. Today it is 
widely accepted that the native state of the protein is the most energetically favourable 
one on the potential energy surface. Each state assumes a certain position on the 
mentioned surface, which means that not all states are equal in free energy and hence 
the search for the native fold can not be unbiased. The way this view has evolved from 
Levinthal's paradox is described in the next section. 
1.2.2 Models of protein folding 
There have been many propositions for explanation of how the conformational space is 
restricted so that the folding time is reduced to the experimental range. The earliest 
ideas by Levinthal were that there exist specific pathways for folding. By restricting 
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the molecules to those pathways the polypeptide chain does not need to undergo an 
extensive search of all the conformational space [24]. In 1973 Anfinsen [25] proposed 
that the information coded in the amino acid sequence of a protein completely deter-
mines its folded structure and that the native state is the global minimum of the free 
energy. Later, a variety of theories emerged, for example the framework model [26], 
the diffusion-collision model [27], the nucleation model [28], the hydrophobic-collapse 
model [29] and the jigsaw model [30]. The hydrophobic-collapse and the framework 
models were favoured over the nucleation model, because they imply the existence of 
folding intermediates, which were discovered soon after. All proposed mechanisms and 
models were able to explain particular pieces of experimental data, but none provided 
a clear explanation of the folding principles or a solution to Levinthal's paradox. 
A real progress has been made recently towards the acceptance of a "new view" 
of protein folding by the scientific community. The reasons for such a change are partly 
due to an increasing demand for an explanation of the mechanism of folding, raised by 
the resolution of numerous protein structures in the post-genomic era. Another reason is 
that with new biophysical technology, experiments providing information about protein 
folding on an atomic level and with real-time resolution have been providing more 
experimental data that can be used to test theoretical predictions. Finally, there have 
been major advances in theoretical approaches that simulate folding using simplified 
models in computational analysis [31, 32]. Protein folding is a perfect example of 
science, where theory and experiment have become crucially inter-dependent for each 
other's affirmation. 
The unified view of protein folding presented in a recent highly cited review by 
Dobson et al [32], underlies the fact that protein folding is a progression in which both 
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native and non-native contacts stabilise native-like structural features. The folding 
either proceeds through a hydrophobic collapse to a compact globule that has stabilising 
interactions or through a slow formation of a folding core (nucleus), which then rapidly 
proceeds towards the native state. Folding is seen as a step-wise behaviour, sampling 
regions of structure that are downhill in energy. 
An important element in the "new view" of protein folding is the folding funnel, 
which was first introduced by Onuchic et al (33). This is one way of representing the 
folding landscape with the free energy (enthalpy and entropy) as a function of folding 
progress variable, also known as the fraction of the native contacts. In the light of this 
simple surface (see Figure 1.6), it is possible to understand a number offeatures of the 
folding process. There are three kinds of states that can be easily distinguished in the 
folding funnel. 
Energy 
molten 
globule/ 
native protein 
C01Jiguration 
Figure 1.6: Protein folding funnel: Schematic of the folding energy landscape, where the 
energy of the protein is displayed as a function of the topological arrangements of the atoms 
(adapted from Schultz et at [34]). 
The initial state from which the folding proceeds is extremely heterogeneous and 
encompasses a large conformational space of rapidly inter-converting states. Nowadays, 
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it is generally accepted that the unfolded or denatured states are not completely random 
coil as one would expect for a polymer. They have intrinsic propensities for native and 
non-native like interactions, which funnel the folding process either through global or 
local conformational preferences [35]. Compact denatured states, commonly known as 
molten globules, are lower in energy in the folding funnel. These have been in the past 
defined with a set of well-defined features such as a set of secondary structural elements 
in the absence of tertiary structure. In contrast, at the bottom of the funnel we find 
a highly compact state, where the close packing of the side chains is essential for a 
well-defined conformation. This is the so-called native state. The important lesson 
that scientists have learned in the past 30 years is that the search for stability and 
the native fold is far from random. Therefore Levinthal's paradox can be considered 
resolved. 
1.2.3 Protein folding and disease 
The understanding of the protein folding process is not only a great intellectual chal-
lenge, but also a crucial step in the development of strategies to prevent and treat 
some debilitating human diseases. Evolution provided proteins with the ability to fold 
to their unique functional states in the most complex cellular environments, but under 
some conditions the proteins are unable to fold correctly or to remain correctly folded. 
This failure can result in a wide range of diseases, some of which are mentioned in 
Table 1.1. 
One group of diseases are amyloid diseases, which include many of the most de-
bilitating conditions in modern society, particulary those associated with ageing, for 
example type II diabetes and Alzheimer's disease. Some are familial, some associated 
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I Disease 
Hypercholesterolaemia 
Cystic Fibrosis 
Phenylketonuria 
Huntington's 
Marfan syndrome 
Osteogenesis imperfecta 
Sickle cell anaemia 
al-Antitryspin deficiency 
Tay-Sachs disease 
Scurvy 
Alzheimer's disease 
Parkinson's disease 
Creutzfeldt-Jakob's disease 
Familial amyloidoses 
Retinitis pigmentosa 
Cataracts 
Cancer 
I Protein 
Low-density lipoprotein receptor 
Cystic fibrosis transmembrane regulator 
Phenylalanine hydroxylase 
Huntingtin 
Fibrillin 
Pro collagen 
Haemoglobin 
al-Antitryspin 
{3-Hexosaminidase 
Collagen 
{3-Amy lo id/ presenilin 
a-Synuclein 
Prion protein 
Transthyretin/lysozyme 
Rhodopsin 
Crystallins 
p53 
Table 1.1: Representative protein folding diseases: data taken from Dobson [36]. 
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with medical treatment (e.g. haemodialysis), or infection (e.g. prion diseases), others 
are sporadic (e.g. most forms of Alzheimer's). Some of these diseases can be even found 
in both sporadic and familial forms, for example amyloidoses associated with protein 
transthyretin. Diseases such as Creutzfeldt-Jakob's, Alzheimers's, type II diabetes and 
systemic amyloidosis are all associated with the deposition of proteinaceous aggregates 
in a variety of organs, such as the liver, heart and brain [35]. These diseases are 
described as "amyloidoses" because the aggregated material stains with dyes such as 
Congo Red in a manner similar to starch (amylase), so the aggregates are termed "amy-
loids" and the typical fibrous structures as "amyloid fibrils". In addition, some diseases 
such as Parkinson's and Huntington's disease appear to involve very similar aggregates 
intracellularly rather than extracellularly, so are not strictly part of amyloidoses. 
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1.3 Formation of disulfide bonds 
1.3.1 Studying oxidative folding 
In proteins, which contain cysteine residues, disulfide bonds are a central feature of 
their native tertiary scaffold. A composite process that includes both the recovery of 
native disulfide bridges (disulfide bond regeneration) and the native three-dimensional 
structure (conj ormational folding) is called the oxidative folding process [37]. A com-
plete account of an oxidative folding reaction should therefore ideally entail an analysis 
of the conformational assembly and a study of the disulfide species that appear in the 
process. 
The conformational folding process is most commonly studied by inducing the 
removal of the native protein structure (either by a high concentration of a denaturant, 
extreme temperature or pH), which is followed by monitoring the structural changes 
that take place as the protein is allowed to regain its native fold. The proteins can 
spontaneously refold in vitro to their native structures and this is followed by physico-
chemical, mostly spectroscopic methods, for example circular dichroism (CD), nuclear 
magnetic resonance (NMR), fluorescence or UV absorbance. These kinds of studies 
can give information at the level of a single residue and even a single atom in the 
polypeptide structure and are hence most versatile for looking at restorations of native 
secondary and tertiary structures. 
On the other hand, the elucidation of the exact role that disulfides play in the 
process is traditionally studied by a time-resolved RP-HPLC (reversed-phase high per-
formance liquid chromatography) analysis of acid trapped samples from an oxidative 
folding reaction. The regeneration of native disulfide bonds involves both the oxidation 
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- ~ RI-S + R2, ..... S., -
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+ R3-S 
B 
+RSH 
Figure 1. 7: Disulfide formation via thiol-disulfide exchange mechanism: A. Thiol-
disulfide exchange mechanism: in the pH range above 8, cysteine thiols are readily converted 
to thiolate anions (RS-) , which are potent nucleophiles. RS- anions attack a disulfide bond, 
displacing one sulfur atom and forming a new bond with the other sulfur atom ( nucleophilic 
substitution). The rate determining step of this concerted process is the formation of a transition 
state with a partial transfer of the negative charge (b-) over the three sulfur atoms [38]. B. 
The formation of a disulfide bond on the polypeptide chain (solid curve) with the help of a 
small molecule reagent (thiol form: RSH, disulfide form: RSSR). The two steps both proceed 
via a thiol-disulfide exchange reaction. In order to be able to follow the mechanism of exchange 
between sulfur atoms, each atom has been given a different colour. The first step shown is 
intermolecular and the second intramolecular. The rate of the intramolecular step is relevant 
to protein folding, since it involves also conformational folding process. 
of thiols and their isomerisation (reshuffling) from non-native to native disulfide bonds 
(via thiol-disulfide exchange mechanism, Figure 1. 7). The study of oxidative folding 
in vitro can provide a detailed structural description in terms of disulfide intermediate 
species present along the pathway of the complex folding process. Such pathways de-
pend on the proximity, reactivity and accessibility of cysteine residues in the protein 
sequence. The real advantage of this approach is the fact that it allows the intermediate 
species to be isolated and to be studied in detail, because they are stable and covalent. 
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1.3.2 Model system studies 
Several disulfide-rich proteins have been characterised showing a complex diversity 
among their oxidative folding pathways. These pathways can be distinguished in terms 
of heterogeneity, abundance and disulfide structure of the intermediate species that 
accumulate during the oxidative folding process. 
BPTI's folding pathway was the subject of an intense dispute in the early 1990's [39], 
but later resulted in one of the most extensively studied oxidative folding pathways and 
a major protein folding model. It was much earlier (1977) that Creighton [40] pioneered 
the technique by doing the analysis of BPTI's folding with iodoacetamide trapping of 
disulfide intermediate species and a subsequent ion-exchange chromatography separa-
tion. A subsequent landmark study by Weissman and Kim in 1991 [41] done with acid 
trapping and HPLC analysis, revealed a slightly different pathway, because the inter-
mediates with non-native disulfide bridges were detected at much lower concentrations. 
Two important questions for any kind of oxidative folding analysis were raised from the 
extensive studies of BPTI. The first one is whether the most abundant intermediates 
are also the kinetically important species for the pathway and the second one is about 
the appropriate conditions of study, for example the pH value that can vary from 7.0 
to 8. 7. With some differences, BPTI's pathway was characterised by both groups with 
the predominance of only a limited number of folding intermediates, that adopt mainly 
native disulfide bridges and native-like structures [42, 43, 44, 45, 46]. It is important to 
remember that 1- and 2-disulfide intermediates were present, but no 3-disulfide species 
apart from the native protein was detected on this pathway. One of the most abundant 
intermediates is a two disulfide species with two native disulfide bonds and a native-
like structure. Formation of the third disulfide (Cysl4-Cys38) is the last step of the 
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folding process. A prevalence of the native-like structures and native disulfide bridges 
points to the conclusion that non-covalent interactions that are specific to the amino 
acid sequence can guide the initial stages of the folding process and hence admit a very 
limited number of disulfide species on the pathway. 
Using the same technique of acid-trapping and HPLC analysis, Chang et al have 
analysed folding and unfolding of a number of small three-disulfide proteins and found 
distinctive mechanisms, which reflect distinctive ways the native disulfide bonds in a 
protein are formed. There are two novel features of the studies of hirudin [ 4 7, 48], potato 
carboxypeptidase inhibitor (PCI) [49, 50], tick anticoagulant peptide (TAP) [51, 52], 
epidermal growth factor (EGF) [53, 54] and some other proteins [55, 56, 57]. The 
first one is that some pathways show a greater heterogeneity of one- and two-disulfide 
intermediates, for example hirudin has about 40 such species. The second one is that 
some of these proteins have intermediates with three-disulfides, including some non-
native bonds. 
Various aspects of disulfide formation, folding and unfolding have been stud-
ied for ribonuclease A (RNaseA) [58, 59, 60, 37, 61], which has become another well 
understood model system. The making of the four disulfide bonds of RN aseA pro-
ceeds through a pre-equilibrium stage with ensembles of unstructured species, followed 
by rate-determining steps involving the conversion of two native-like three disulfide 
species to the native protein. Ribonuclease A is another good example of a protein 
that develops native disulfide bonds, which cause stable native-like tertiary structures 
in intermediate species. However, Scheraga et al [37] do not recognise that the ox-
idative folding mechanism can also produce stable tertiary structures, resulting from 
non-native disulfide bridges, despite the extensive studies by Chang et al mentioned 
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above and the published structures of such intermediates [62]. 
The formation of disulfides in numerous other proteins has been studied, for 
example hen lysozyme [63, 64, 65, 66], insulin-like growth factor [67, 68, 69], various 
toxins [70, 71], nerve growth factor [72], cyclotide kalata Bl [73] and others. 
1.3.3 Catalysts of oxidative folding in vivo 
Disulfide bonds are created in vivo, along with other post-translational modifications, 
in the endoplasmic reticulum (ER) of eukaryotes and the periplasm of Gram-negative 
bacteria. Already Anfinsen et al [25] predicted that proteins require a sufficiently ox-
idising environment (i.e. in the ER, the reduction potential is negative: E'=-0.18 V) 
in order to form their disulfide bonds. They had not envisaged, however, the complex-
ity of the oxidative folding reaction and the numerous proteins and small molecules 
which help in achieving the right disulfide pairing. Furthermore, the long-held hy-
pothesis that glutathione is the primary oxidant in the ER has been disproved despite 
the millimolar concentrations of both the reduced and the oxidised form found in this 
compartment [74]. On the other hand, the catalytic activity in many cellular compart-
ments, as well as in the ER, is being attributed to chaperones. They are molecules 
that bind partially folded or misfolded proteins in a transient or permanent manner to 
facilitate folding and prevent aggregation [75]. 
The currently accepted hypothesis is that the major catalysts of disulfide forma-
tion are proteins of the thioredoxin family. Thioredoxins are redox proteins that cycle 
between the reduced (dithiol) and the oxidised (disulfide) form of the sequence Cys1-X-
X-Cys2 situated at their active site. The thiol group of the accessible Cys1 reacts with 
protein disulfide bonds to generate a mixed transient disulfide, which is displaced by 
1.3. Formation of disulfide bonds 21 
the adjacent group of the second, buried Cys2 residue to form the thioredoxin disulfide 
bond. This is a mechanism very similar to the described thiol-disulfide exchange reac-
tion in Figure 1. 7. Thioredoxins catalyse three types of reactions: formation, reduction 
and isomerisation of disulfide bonds and they also display chaperone activity in vivo 
and in vitro. 
In the major pathway of eukaryotic cells for disulfide bond formation the oxidising 
equivalents fl.ow from ER oxidation 1 protein (Erolp in yeast, Erol-L in human) to 
Protein Disulfide Isomerases (PDI). Erolp was discovered in 1998 to directly oxidise 
PDI protein, which in turn oxidises a variety of newly synthesised proteins [76, 77, 
78]. Erolp is an essential membrane associated fl.avoenzyme and has two pairs of 
conserved cysteine residues, which are likely to form redox active disulfide bonds. The 
eukaryotic PDI family of enzymes [79] (i.e. human PDI and yeast PDilp), on the 
other hand, are four-domain (a, a', b, b ') enzymes known to have two catalytic sites 
consisting of the Cys-His-Gly-Cys motif, which are situated in the a and a' domains. 
The structures of the a and b domains were determined separately by NMR and they 
both belong to the thioredoxin fold [80, 81 ]. PDI enzyme was first isolated from liver 
in 1966 by Anfinsen [82], but has since been found in a variety of tissues and its gene 
is highly conserved across organisms. The crystal structure of a complete bacterial 
homologue, DsbC (Figure 1.8) has been recently resolved [83] and provides a model for 
PDI structure. 
DsbC contains two C-terminal catalytic domains and two N-terminal dimerisation 
domains, which is reminiscent of the four thioredoxin-like domains of PDI. It is one 
of the seven proteins, which are involved in the formation of disulfide bonds in the 
bacterial periplasm (DsbA to DsbG). The V-shaped dimer structure has the catalytic 
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Figure 1.8: Protein disulfide isomerase, DsbC, structure: ribbon diagram of the homod-
imer with the atoms of two active sites shown in green spheres (Cys98-Pro99-Tyr100-Cys101). 
The N-terminal residues (1-61) of each monomer form the dimerisation domains, whereas the 
C-terminal domains (residues 78-216) have each a thioredoxin and a helical subdomain. The 
broad hydrophobic cleft in the middle is large enough to bind small protein domains ( dimen-
sions: 40x40x25 A) . 
sites pointing towards each other across the broad hydrophobic cleft, which is important 
for binding of unfolded proteins and may be involved in chaperone and disulfide bond 
isomerase activity. 
Another protein that can oxidise PDilp in yeast independently of Erolp is the 
flavoenzyme Erv2p (Essential for respiration and viability 2 protein). Its function 
in the ER and three-dimensional structure have been recently determined [84, 85]. 
Unlike Erolp, Erv2p binds the luminal flavin adenine dinucleotide (FAD) tightly and 
is oxidised directly by 02 in order to transfer disulfide bonds to PDilp. The strained 
loop created by a disulfide bond between the residues Cysl 76 and Cysl 78 is a good 
oxidising agent and its active site, composed of Cys-Gly-Glu-Cys residues, is located on 
the N-terminal a3 helix. The Erv2p pathway for biosynthetic disulfide bond formation 
is the first to identify the ultimate electron acceptor, 02 [84]. 
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1.4 Aim and scope of the thesis 
This introductory chapter provides scientific background for the thesis, which elucidates 
the oxidative folding process of the a-amylase inhibitor from Amaranthus plant seeds. 
The analysis of this process is aimed to describe it both at the level of the disulfide 
species and the three-dimensional conformations, which are formed along the pathway. 
The scope of such a study is two-fold. On one hand it contributes to the solution of 
the protein folding problem(s) and at the same time it focuses at discoveries of new 
biological phenomena and at developing novel biophysical techniques for the future 
studies of protein folding. 
Chapter 2 
Experimental techniques 
2.1 Where theory meets the experiment 
The biophysical and biochemical b?-sis of protein folding has been a challenging and 
fascinating topic in theoretical and experimental studies for more than three decades. 
A major goal for such studies is the development of a model that can make predictions 
about the effect of various factors on the kinetics and thermodynamics of the folding 
process [86]. The development of such a model requires an interdisciplinary approach, 
involving a range of biochemical and biophysical techniques that study structure, dy-
namics, energetics and mechanism. Further, these techniques need to be applied to 
numerous proteins in order to be able to draw trends and patterns between various 
systems and make a successful hypothesis of a protein folding model. 
The present chapter introduces the techniques used to elucidate the oxidative 
folding of Amaranthus a-amylase inhibitor (AAI). Each section includes a historical 
and theoretical background of the technique, followed by the experimental details used 
in the study of AAI protein. An emphasis is made on nuclear magnetic resonance 
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(NMR) spectroscopy and its application in photo-chemically induced dynamic nuclear 
polarisation (photo-CID NP), because a substantial proportion of the data was obtained 
with these techniques. 
2.2 Solid-phase peptide synthesis 
2.2.1 The Merrifield technique 
The solid phase peptide synthesis technique was pioneered by Bruce Merrifield in 
1963 [87], when he published a single author paper describing the synthesis of the 
tetrapeptide Leu-Ala-Gly-Val by successive addition of benzyloxycarbonylamino acids 
to a polystyrene resin. The principle of his approach was that any growing chain, be it 
a peptide, oligonucleotide or other oligomer is elaborated while being attached to a sta-
ble solid support. There are numerous advantages of this approach over the traditional 
solution-phase synthesis: 
• all reactions are carried out in a single vessel 
• excess reagents drive reactions swiftly to completion and are easily filtered from 
the system, eliminating the need for purification of intermediates after each step 
• many repetitive steps enable the automation of the whole process 
On the other hand, the solid phase peptide synthesis has the disadvantage of being 
insensitive to many analytical techniques for the characterisation of intermediates of 
the reaction and also by causing insoluble by-products by incomplete reactions. At the 
beginning some peptide chemists were very reluctant and critical of the approach, but 
time has shown that its advantages have clearly outweighed its disadvantages. 
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2.2.2 Protecting groups and formation of a peptide bond 
Peptide synthesis requires selective protection (blockade) of the reactive amino and 
carboxy groups in amino acids to obtain the desired peptides and form correctly the 
peptide bond between the amino acid building blocks. Any coupling of amino acids in 
peptide synthesis therefore requires coupling of protected amino acids, followed a by 
deprotection step. 
The criteria for a successful protection of the a-amino group during peptide 
synthesis are demanding. It needs to suppress its nucleophilic activity either by drain-
ing the electron density into an appropriate substituent or by concealing it with a 
screen of steric hindrance. The most important protecting groups for both historic 
and experimental reasons are Benzyloxycarbonyl (Z), t-Butoxycarbonyl (Boe) and 9-
Fluorenylmethoxycarbonyl (Fmoe) protecting groups, which are shown in Figure 2.1. 
The discovery of the Z group (Bergmann and Zervas in 1932 [88]) is regarded a turn-
0 
0 o~ uo~ o~ 
H3C+CH3 0 
CH3 
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Figure 2.1: a-amino protecting groups: Benzyloxycarbonyl (Z-), t-Butoxycarbonyl (Boe-) 
and 9-Fluorenylmethoxycarbonyl (Fmoc-). 
ing point in the origin of modern peptide synthesis. In the 1960s, as the solid state 
approach was appearing, Boe and Fmoe groups were becoming more popular. 
The side chain protecting groups are attached either to the amino acid side-
chains or carboxy terminal resin linkage. They can all be cleaved off ( deprotected) 
simultaneously in a single step after the synthesis is complete. The choice of benzyl 
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ester for the peptide linkage to the resin strongly favors similar protection of the amino 
acid ends: benzyl ether, thioether, ester and urethane. 
As far as solid supports are concerned, the widely used polyamide supports were 
introduced by Sheppard and co-workers [89, 90]. It was desirable to have a polymeric 
carrier which would be readily solvated in dipolar organic solvents together with the 
peptide chain. This system would be similar to an open gel system in which there is 
an easy access for reagents to the active sites. 
Today, there are mainly two well described and known approaches: the Merrifield 
and the Sheppard approach. The Merrifield technique is synonymous to the Boc-
polystyrene implementation, whereas the Sheppard technique uses Fmoc-protection on 
polyamide supports. Most steps of both approaches are very similar and are outlined in 
Figure 2.2. Solid phase peptide syntheses start with an addition of protected amino acid 
in an excess amount to the amino resin in a non-polar solvent such as dichloromethane. 
After the first amino acid has been reversibly linked to the solid support, a series 
of repeated reaction cycles follow for each residue added to the support. The three 
most important steps for each residue are deprotection in mildly acidic conditions, 
neutralisation and acylation. 
2.2.3 Synthesis of AAI peptide 
The protected peptide chain was assembled on a 2-chlorotrityl resin (Alexis corpo-
ration) to which the first amino acid Fmoc-Ser(tBu)-OH was manually introduced. 
The chain assembly was carried out manually on a 0. 750 mmol scale and the ini-
tial substitution rate was 0.283 mmol/g. A protection scheme was used, which could 
be cleaved in a single step after the synthesis was completed (triphenylmethyl, Trt: 
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Figure 2.2: Solid Phase Peptide Synthesis steps with Boe-strategy: 1. salt formation, 
2. esterification by nucleophilic displacement, 3. deprotection in mildly acidic conditions, 4. 
neutralisation, 5. coupling, 6. repetition of steps 3-5, 7.vigorous acidolysis. Adapted from 
Jones (91]. 
Cys, Asn; tert-butyl, tBu: Tyr, Ser, Thr; tert-butyl ester, 0-tBu: Asp, Glu; tert-
butoxycarbonyl, Boe: Lys, Trp; Pbf: Arg). Single couplings were carried out for 60-
120 min using in situ Fmoc-amino acid with HOBt/TBTU/DIEA, apart from cysteine 
residues, which were introduced as Fmoc-Cys(Trt)-OPfp with HOBt/TBTU /DMP. 
Double couplings were necessary at the following positions: 1, 2, 3, 4, 5, 6, 7, 8, 
11, 23. Fmoc-removal was with 20% piperidine in N-methylpyrrolidinone (NMP). The 
synthesis was monitored at each coupling step. Kaiser test [92] was performed to test 
for unreacted primary amines left on the resin after the coupling of every amino acid 
residue apart from proline, after which chloranil test [93] is more suitable and tests for 
secondary amines. Cleavage/deprotection mixture (20 ml/g peptide resin) containing 
TFA:H20:phenol:EDT:TIS = 81.5:5:5:2.5:1 was prepared fresh prior to use. The pep-
tide resin was left in the cleavage mixture for 3h, after which the molecular weight was 
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checked with ESI-MS. The peptide mixture was filtered separately from the resins and 
washed with TFA, then evaporated at room temperature in vacuo. The peptide solu-
tion was precipitated with 20 volumes of cold diethylether, the pellets were separated, 
washed with ether (3x 30 ml) and dried. 
2.3 Chromatographical techniques 
The International Union of Pure and Applied Chemistry (IUPAC) states that chro-
matography is a physical method of separation in which the components to be sepa-
rated are distributed between two phases, one of which is stationary while the other is 
mobile (either gas or fluid) and moves in a definite direction. 
Tswett is considered the inventor of column chromatography and was the first to 
publish a paper in 1906 about its use [94]. He described the separation and isolation of 
intensely colored green and yellow chloroplast pigments and therefore named the tech-
nique after chromatos, the Greek word for color. However, the foundation of modern 
liquid chromatography is considered to be laid by Martin and Synge in 1941 [95], when 
they published a paper on separation of amino acid mixtures. In the following post-war 
years until the 1960s, many different methods were developed such as thin layer chro-
matography (TLC), gas liquid chromatography (GLC), ion-exchange chromatography 
(IEC) etc. The development of HPLC was much slower. It is the most widely used 
technique nowadays and can be extended to any form of column chromatography with 
a liquid mobile phase. At first, in the 1970s, long-chain hydrocarbons were bonded to 
the surface of silica beads and used as a stable stationary liquid phase, but this pro-
duced high back pressure, which is why the name high pressure liquid chromatography 
(HPLC) was associated with it. In the late 1970s, short columns with small particles 
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were introduced to achieve faster separations with better efficiencies, which renamed 
HPLC into high performance liquid chromatography. 
2.3.1 HPLC techniques 
Chromatographic processes in HPLC can be classified according to the type of station-
ary phase, which refers to the solid support contained within the column over which the 
mobile phase continuously flows. Columns containing various types of stationary phases 
are commercially available. Some of the more common types include: adsorption, size 
exclusion, normal phase, reversed-phase, ion exchange and affinity. 
One of the most common HPLC techniques, which was used for the analysis of 
protein samples in this thesis is the so called Reverse Phase-HPLC (RP). It operates 
on the basis of hydrophilicity and lipophilicity. The stationary phase consists of sil-
ica based packing with covalently bound n-alkyl chains. For example, C-8 signifies an 
octyl chain and C-18 an octadecyl ligand in the matrix. The more hydrophobic the 
matrix on each ligand, the greater is the tendency of the column to retain hydrophobic 
moieties. By means of using gradients between hydrophilic (mostly water) and hy-
drophobic (usually acetonitrile) solvents, mixtures are separated on the basis of their 
hydrophobicity. Separation occurs as the mobile phase with the sample passes over the 
stationary phase and the compounds of interest are retained. Two other widely used 
techniques are Ion-Exchange (IE) and Affinity Chromatography. IE is performed with 
columns containing charge-bearing functional groups attached to a polymer matrix. 
Affinity, on the other hand, operates by using immobilized biochemicals that have a 
specific affinity to the compound of interest. 
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2.3.2 RP-HPLC chromatography with AAI protein 
Analytical and preparative reversed-phase HPLC were carried out on a GILSON sys-
tem. It is configured with an 805 manometric module, an 811C dynamic mixer, two 
model 306 pumps, 118 UV /VIS detector, computer controlled GILSON 506 C system 
module and Unipoint system software. Samples were eluted with linear gradients of 
solvents A (H20 / 0.1% TFA) and B (CH3CN / 0.1% TFA), unless specified other-
wise. Analytical separation was done on a ZORBAX 300 SB-5C18 (150 x 4.6 mm, ID, 
Hewlett Packard) column at flow rates of 0.8-1.0 ml min-1. Preparative RP-HPLC was 
done on a Waters Prep LC Universal Base Module with a Prep-Pac cartridge Delta Pac 
300 ·15RC18 (100 x 40 mm, ID, Waters) column at a flow rate of 15 ml min-1. 
2,4 ESI-MS and protein structure .• -·' 
Mass spectrometry detects the mass to charge ( m / z) ratio of molecular ions and th2if. 
frn,gments that are produced after ionisation, for example after an electron impact: '' 
(2.1) 
Molecular ions reveal information about the molecular weight and structure of their 
precursor molecule. A mass spectrum is a plot of the relative abundance of ions vs. 
their m / z ratio. Electrospray ionisation (ESI) is one of the most widely used ionisation . 
techniques in mass spectrometry of biomolecules. It is produced by applying a strong 
electric field under atmospheric pressure, to a liquid with a weak flux, passing through 
a capillary tube. The electric field is obtained by applying a strong potential difference 
of 3-6 kV between the capillary and the counter electrode, separated by 0.3-2 cm. 
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Highly charged droplets are formed, which shrink as the neutral solvent evaporates. At 
a certain point the charge repulsion forces overcome the cohesion forces, which causes 
a Coulombic explosion. The mechanism of the field evaporation of charged surfaces is 
still unclear, but the important fact is that molecular ions are produced, which can be 
detected in a mass spectrometer. 
The atmospheric pressure ionisation (API) is 103-104 times more efficient than 
at a reduced pressure of an electrospray ionisation source. The problem remains in 
coupling the atmospheric source compartment with an analyser compartment, which 
needs to be kept at very low pressure (10-5 Torr). The problem is solved by introducing 
a very small opening between the compartments and by using high-capacity vacuum 
pumps. The needle which is maintained at high voltage encounters a counterflow of 
warm gas (typically N2 at 45-75°C), which sweeps away the uncharged material and 
solvent vapor. Ions enter as a free jet expansion into a skimmer and then into the inlet 
optics of the mass analyser. This procedure is shown schematically in Figure 2.3. This 
app:r;oach allows a liquid chromatography apparatus to deliver the sample to the ion 
spray, which has been used for applications in analytical chemistry and biochemistry. 
2.4.1 Mass spectrometry of proteins 
The ESI-MS technique was primarily developed by Fenn and co-workers, who have pi-
oneered the sampling of ions at atmospheric pressure coupled with quadrupolar detec-
tion. Apart from molecular weight determination of biomolecules, the other application 
of this technique is its use as an interface for coupling of mass spectrometry with liquid 
chromatography. The multiple protonation of basic residues in the ESI mass spectra of 
proteins extended the mass range to more than 1,000,000 Da with quadrupole detection 
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Figure 2.3: Electrospray ionisation (ESI) mass spectrometer: Schematic illustration of 
atmospheric pressure ionisation (API) electrospray technique. ESI operates by infusing a liquid 
containing the sample of interest through a capillary, whose outlet is in an electric field. This 
causes the liquid to disperse into fine droplets which are eventually desolvated to release ionized 
species into the gas-phase. 
and a precision of 0.01 % in the 5-40 kDa mass range. 
The molecular mass can be calculated by deconvolution of multiply charged peaks 
into the singly charged peaks. For positive and negative ions, respectively, the following 
equations are given for calculation of the molecular mass: 
M (2.2) 
M (2.3) 
where z1 is the charge and ri is the m/ z ratio of a molecular ion and mp is the 
proton mass, which is included because the API occurs by loss or gain of a number of 
proton(s). Calculation of M for each of the observed m/ z values enhances the precision 
of the estimation with an experimental error < 0.01 %. 
The ESI-MS spectra normally contain a series of peaks which have a statistical 
distribution of intensities. They represent multiply charged molecular ions obtained 
through protonation or deprotonation. The number of peaks in the spectrum is usually 
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about half the number of the most abundant charge state. Monitoring the behaviour 
of the series of peaks produced in the electrospray ionisation process, the charge state 
distribution (CSD), was one of the first application of ESI-MS to protein structural 
studies. It has been shown that proteins in their native conformation, for example, 
give narrow CSD, whereas under denaturing conditions proteins give spectra with a 
broad series of lines, centered around a higher charge [96]. Another application of 
ESI-MS which has been widely studied is the exchange of labile protons with solvent 
deuterons [97]. This method provides global and local information on the dynamic 
properties of proteins on the basis that protons in the hydrophobic core or those in-
volved in hydrogen bonding will have exchange rates several orders of magnitude slower 
that the solvent exposed ones. Problems such as folding, stability and protein-DNA 
interactions have been successfully studied with ESI-MS [98, 99]. 
In the last ten years, we have seen an increasing emergence of a variety of systems 
combining liquid chromatography and mass spectrometry (LC-MS). This is a very pow-
erful analytical tool for the study of biological phenomena at the molecular level, which 
synergistically combines the advantages of both techniques to give better information. 
The mass spectrometer has an increased ionisation efficiency due to a pre-separation of 
the compounds in the sample. Essentially, it allows to determine molecular mass and 
structural characteristics of all the peaks in a chromatogram. This technique incorpo-
rates steps such as desalting and pre-concentration and prevents sample handling loss. 
The disadvantages of this system include the relatively high costs of equipment and 
operation and the limited column and buffer types of the LC system. 
2.5. Circular Dichroism 35 
2.4.2 ESI-MS experiments with AAI 
Electrospray ionisation mass spectrometry experiments were performed on a Perkin 
Elmer API 150 EX electrospray, single quadrupole mass spectrometer, with a resolution 
of 3000 Da. The samples were analysed in positive mode either by direct syringe 
infusion or via a LC-MS system. The direct syringe infusion was done by a Harvard 
Apparatus (pump type 11) at flow rates 20-50 µI/min. The protein samples were either 
dissolved in various proportions of water and acetonitrile or analysed immediately after 
the elution from a RP-HPLC coloumn. To keep the samples at pH 2 for successful 
analysis in positive mode for ESI, a total of 0.1% TFA was present. In the case of the 
LC-MS system, a Gilson micro-flow system was configured with an 805 manometric 
module, an 811C dynamic mixer and two pumps (models 305 and 306). A micro bore 
rapid resolution column (Agilent Zorbax 300 SB-C18, LO x 150 mm, 3.5 µm) was 
connected to the API electrospray to run water/ actetonitrile gradients at flow rates 
40-50 µI/min. The molecular weights of the peptides and the masses for theoretical 
digestion of the intermediates were calculated using the Applied Biosystems software 
(programmes BioMultiview and ProMac). 
2.5 Circular Dichroism 
2.5.1 Circular dichroism of proteins 
Circular dichroism (CD) spectroscopy is a form of light absorption spectroscopy that 
measures the difference in absorbance of right- and left-circularly polarized light. A 
circularly polarised beam is the result of an addition of two plane polarized light beams 
perpendicular to each other with a quarter wave phase offset. Circularly polarized 
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Figure 2.4: Circularly polarised light is composed of two plane waves (denoted with red 
and green) of equal amplitude by differing in phase by 90°. The tip of the field vector appears to 
be moving in a circle as it travels through time. If it appears to be rotating clockwise, the light 
is said to be right-circularly polarized, otherwise (counter-clockwise rotation) it is left-circularly 
polarized light. The electric field vector makes one complete revolution as the beam advances 
one wavelength, as denoted by the distance A on the time axis. Adapted from 0.Smart with 
permission (http: //bach.bip.bham.ac.uk/osmart). 
light has constant magnitude of the oscillation and oscillating direction, as shown in 
Figure 2.4. Right- and left-circularly polarized light will also be absorbed to different 
extents at some wavelengths due to differences in extinction coefficients for the two 
polarized rays. The differential absorption of radiation polarized in two directions as a 
function of frequency is called circular dichroism (CD). 
There exists a number of ways the CD of a sample is reported in the litera-
ture. The most commonly used units are mean residue elipticity (degree cm2 dmo1- 1). 
Equation 2.4 gives the relationship between elipticity, 8, and mean residue elipticity, 
[8)MRE· 
mean residue elipticity [8)MRE 8 ====? [degcm
2
] 
10 n cl dmol (2.4) 
Circular dichroism of proteins is mainly concerned with absorption in the ultra-
violet region of the spectrum where signals from the peptide bonds and amino acid 
side-chains can give various information about protein structure [100). In the far-UV 
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region (240 nm to 190 or 180 nm), the principal absorbing group is the peptide bond. 
These studies can be used to quantitatively evaluate the secondary structure of the 
protein, because regular secondary structure gives distinct spectra. In the near-UV 
region (320 to 240 nm) the aromatic side chains (Phe, Tyr, Trp) absorb in the range 
250 to 290 nm. The chiral environments of these side chains, created by the tertiary 
structure of the protein, give rise to CD spectra, which can be used as fingerprints 
of the specific structure. Additionally, broad signals at around 260 nm belong to the 
absorbance by disulfide bonds. Their intensity depends on different bond angles and 
the effects of the neighboring groups. 
The principal advantages of CD derive from its speed and convenience as good 
quality spectra can be obtained within 30 min [101]. Further, low amounts of material 
(compared to for example NMR) are required and the technique is non-destructive, 
samples being re-usable for further analysis. It is easy to study a wide range of protein 
concentrations. The main limitation of CD is the limited structural information avail-
able giving only an estimate of how much of each kind of secondary structure is present, 
but not where exactly it is situated. It also gives little information on the quaternary 
structure of proteins. 
2.5.2 Circular dichroism of equilibrium states of AAI 
Circular dichroism experiments were performed on a Jasco J-810 spectropolarimeter, 
which has a wavelength range from 163 nm to 900 nm and is equipped with Spectra 
Manager software. The spectra both in the far-UV and in the near-UV region were 
acquired with 1 nm step resolution, 50 nm min-1 speed of acquisition, 1 second response 
time, 1 nm band width, averaged over 16 acquisitions and 20 milli-degree sensitivity. 
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In the far-UV region, the cuvette with 0.2 mm path-length was used and the spectra 
were acquired from 190 nm to 260 nm. In the near-UV region, however, a path-length 
of lmm was used to acquire spectra from 240 nm to 320 nm. Reference spectra of the 
buffer in which the protein samples were dissolved, was recorded for both the far-UV 
and the near-UV experiments and they were subtracted from the spectra to obtain the 
difference spectra. The protein concentrations for recording the spectra were 0.1 mM 
and 2 mM in the far-UV and the near-UV regions, respectively. 
2.6 NMR and photo-CIDNP 
The scientific groups of Bloch and Purcell simultaneously published the results of the 
first successful NMR experiments in 1946 [102, 103]. In 1954, only one year after 
Watson and Crick's historic discovery, the first application of NMR to a biological 
sample appeared in Na tu re featuring the hydration of deoxyribonucleic acid [104]. This 
was followed by the first 1 H NMR spectrum of a protein (ribonuclease) at 40 MHz by 
Saunders et al in 1957 [105]. Almost 50 years afterwards, NMR is an extremely wide-
spread technique used in a wide range of scientific disciplines, ranging from physics, 
chemistry, and material science to medicine and recently to the upcoming disciplines 
such as structural genomics and proteomics. The recognition of the NMR field can be 
seen by three Nobel Prizes being awarded to scientists for its discovery, development 
and applications to biomolecular problems: Bloch and Purcell in 1952, Ernst in 1991 
and Wiithrich in 2002. 
Because of the insensitivity of the NMR technique, attempts to enhance the sig-
nals in NMR were pursued thoroughly. An enhancement in emissive and absorptive 
NMR signals was observed in free radical reactions first by Bargon et al [106] and Ward 
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and Lawler [107]. Although this phenomenon was first called dynamic nuclear polar-
isation (DNP), it could not be explained solely on the basis of Overhauser effects. A 
complete explanation of the mechanism was given by the so-called radical pair mech-
anism independently by Closs [108] and Kaptein and Oosterhoff [109]. The effect was 
called chemically induced dynamic nuclear polarisation (CIDNP) and was explained 
to arise from a spin sorting process arising during the recombination of radical pairs, 
which leads to greatly perturbed populations of nuclear spin state levels. A laser in-
duced method named photo-CIDNP was devised by Kaptein to enhance specific signals 
in a protein NMR spectrum [110, 111, 112]. Photo-CIDNP is well understood by the 
RPM and has been applied to many different problems of structural biology. 
2.6.1 NMR theory 
Nuclear spin and magnetism 
Spin is the intrinsic angular momentum of a nucleus. This vector quantity assumes a 
1 
value of magnitude (I(I + 1)) 2 1i and a quantised number (m1=I, J-1, J-2, ... -I+ 1, -I) 
of orientations, both depending on I, the nuclear spin quantum number. In absence 
of a magnetic field the orientation onto which the spin is projected is arbitrary, so all 
the spin levels are degenerate in energy. However, when an external field Bo is applied 
to the sample, this degeneracy is removed by the Zeeman effect. The energy levels are 
consequently split by Di.E (Equation 2.5, where 1i is 1.05 x 10-34 ), which depends both 
on the static magnetic field, Bo, and the gyromagnetic ratio of the nucleus, 1. 
Di.E = 1i1Bo (2.5) 
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Nuclear Magnetic Resonance (NMR) is the phenomenon of induced transitions be-
tween the allowed orientations of the nuclear spin by application of a radio frequency 
field. Transitions between the states are only observed when the resonance condition 
is satisfied: 
hv = n1Bo (2.6) 
When subjected to a magnetic field, the nuclei spread themselves amongst the 21 + 1 
available energy levels according to the Boltzmann distribution (Equation 2. 7). The 
transitions follow the NMR selection rule b..m1 = ±1 (where m1 is the magnetic quan-
tum number and assumes 21+1 values: - l, - l + 1, ... ,I - l ,I) to undergo an excitation 
one level higher or a stimulated emission one level lower in energy. 
(2.7) 
The intensity of the NMR signal reflects the net amount of energy absorbed ( b..E) and 
depends on the difference in population of the two levels between which the transition 
occurs. In NMR, the transitions for which b..m1 = -1 outnumber those, where b..m = 
+ 1, just by about 1 in 104 - 106 , so it is as if the difference in populations is only one 
nucleus in every 104 - 106 . It is therefore crucial to maximize the intensity of NMR 
signals by using strong magnetic fields and to make use of nuclei with high natural 
abundance and large gyromagnetic ratio, 'Y. These considerations make 1 H the most 
popular nucleus for NMR studies and currently magnetic fields up to 21.1 T (900 MHz 
1 H frequency) are commercially available. 
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NMR experiment 
When matter is placed into a static magnetic field, B0 , the large number of spins precess 
around the Bo axis at a speed called the Larmor frequency, or the NMR absorption 
frequency, W£. The Larmor frequency, which can be deduced from Equation 2.6 is 
defined as: 
WL =rBo (2.8) 
In a macroscopic sample at thermal equilibrium the slight excess of spins in the lower 
energy level gives a bulk magnetization, Mo, which is stationary and aligned parallel to 
Bo. According to the familiar vector model, the direction of magnetic field Bo defines 
the z' axis of the static coordinate system (x',y',z'), known as the laboratory frame. 
NMR experiments consist of a series of pulses, which are linearly oscillating magnetic 
fields in the radio-frequency range. Say a pulse is applied around, for example the x' 
axis, with a radio-frequency, WRF (Figure 2.5). It causes the bulk magnetization vector 
to tilt away from the z' axis, precessing about the z' axis at the Larmor frequency. 
In order to view the experiment more easily, we define the rotating frame, which is a 
coordinate system that rotates around the z' axis with the frequency of w RF. A pulse 
is now simply a temporary application of a static magnetic field Bi, orthogonal to Bo. 
After the application of for example a 90° pulse, the magnetization M remains in the xy 
plane generating time dependent radio frequency signals, described as a free induction 
decay (FID) in Figure 2.6B. The more familiar frequency dependent spectra which are 
used in NMR representation are related to the FID through Fourier Transformation 
(Equation 2.10). 
M(t) = Mo exp (i~!lt) exp (-t/T2) (2.9) 
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S(w) = {"' Mo exp (i~flt) exp (-t/T2) dt (2.10) 
~n is the difference between the Larmor frequency, w L and the spectrometer carrier 
frequency, w0 . T 2 denotes the time constant of the exponential decay with which the 
FID decays (explained below). An alternative way of representation how the pulses 
transfer magnetization is the product operator formalism, which is inherently quantum 
mechanical in nature. This formalism describes an NMR experiment in terms of the 
vectors that represent the magnetization in various direction or as a product of vectors 
of various spin systems. They can be used for an exact analysis of modern NMR 
experiments. 
M 
t 
Figure 2.5: 90~ pulse in the rotating frame: Magnetization is first aligned along the z axis 
and precesses about the x axis during the 90°-pulse to reach the xy-plane. Magnetization will 
start to precess at frequency ~n around the z axis as soon as the pulse is switched off. 
Relaxation 
Relaxation makes a sample re-usable for multiple pulses and can be divided into two 
different processes (Figure 2.6A). The populations of the two energy levels return to the 
equilibrium (Boltzmann) distribution due to a process called spin-lattice or longitudinal 
relaxation. This means that the z magnetization recovers its original value. This 
process is approximately exponential and can be described in terms of a single time 
constant. The second process, called spin-spin or transverse relaxation, is due to the 
decay of the xy magnetization back to zero by the randomization of phases of the 
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Figure 2.6: Relaxation and FID: A. Spin-lattice and spin-spin relaxation: the former re-
stores the z magnetization to its original value, whereas the latter returns xy magnetization to 
its equilibrium value of zero. B. The basis of the Fourier Transform technique, that transforms 
the FID signal from the time to the frequency domain. 
2.6.2 Photo-CIDNP theory 
The chemically induced dynamic nuclear polarisation (CIDNP) phenomenon is observed 
as greatly enhanced emission or absorption in NMR signals of products in reactions 
where radical pairs act as intermedia_tes. It originates from the ability of the nuclei 
to alter the electronic spin state of a radical pair so as to alter its reactivity. The 
NMR intensity enhancements obtained using the CIDNP method can be used to study 
radical reaction mechanisms (including determination of spin multiplicity, g-factor and 
hyperfine coupling) and in conjunction with a suitable light source and a sensitiser, a 
photo-CIDNP method was developed, which proved a very powerful tool for the study 
of protein structure and dynamics (110 , 111 , 112, 113, 114, 115, 116, 117]. 
Radical pair mechanism and biological photo-CIDNP 
The radical pair mechanism scheme (108 , 109] may be applied to all CIDNP reactions, 
but the reaction of interest here is a reversible photo-reaction of a dye with an amino-
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acid residue. When an amino-acid residue such as tyrosine, tryptophan, histidine or 
methionine is exposed to a photo-excited dye such as a fiavin, nuclear spin polarization 
can be generated in the side-chains resulting in selective enhancement of NMR lines. 
In Figure 2.7A, a scheme for radical pair mechanism is shown, where a molecule (P) 
is first photo-excited to its singlet state. It then undergoes inter-system crossing to its 
triplet state, after which it abstracts an electron from a do.nor molecule (Q) to form 
a triplet caged-radical pair (primary encounter pair). There are two ways to proceed 
from here. Either through recombination to starting materials through triplet-singlet 
mixing or through separation and formation of escape products with other species. 
The reaction pathway in biological systems differs from the usual radical pair 
mechanism in that it is a cyclic reaction (Figure 2.7B). After the dye is excited to its 
triplet state, both escape and recombination pathways will produce the same products, 
because there are no other molecules available to scavenge the escaped radicals. This 
is essential as CIDNP observed is then of the substance itself and not of a chemically 
modified form. 
It may seem, however, that no CIDNP should be observed as there is only one 
reaction product (native protein) and the equal and opposite polarisations in escape 
and recombination products would cancel each other out exactly. Fortunately, dipolar 
coupling with the unpaired electrons in the escaped radicals makes nuclear spin relax-
ation very efficient, providing that the life-time of the radicals is not much shorter than 
the nuclear spin-lattice relaxation time, Ti. Escape polarisation is relaxed before the 
radicals recombine, so only recombination polarisation is observed as a CIDNP peak. 
A small amount of dye, a photo-sensitiser, is mixed in with the protein solution 
in a NMR tube. The most commonly used dyes are fiavins, which have a visible ab-
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Figure 2.7: Radical pair mechanism (RPM) and cyclic reaction pathway: A. RPM 
guides the reaction of a radical pair by using the nuclear spin state (a or /3) as a label. In 
this example the former (a) leads to the formation of the recombination products. The radical 
pair first undergoes singlet-triplet inter-conversion during diffusion and a reencounter leads to 
recombination. For the latter (/3), it leads to the formation of escape products. The radicals 
P and Q diffuse apart and react with other molecules. B. Cyclic reaction pathway of photo-
CIDNP for proteins: F represents the dye, A stands for the reacting amino acid side chain. The 
asterisk denotes nuclear polarization. Only recombination polarisation is observed as a CIDNP 
peak, because of efficient nuclear spin relaxation in escape products. 
sorption band near Amax=450nm. One of the most widely used, Flavin Mononucleotide 
(FMN), gives excellent signal to noise ratio and amino acid selectivity. One problem 
with flavin dyes is their photo-degradation, which allows typically only 16 to 64 acqui-
sitions per sample. The main source for signal decay is the progressive loss of the flavin 
dye due to its reduction. Several solutions have been proposed to resolve this problem, 
which include the use of a replenishment or mixing device or adding an oxidising agent 
directly to the protein solution, such as H202 [113]. In order to resolve this problem of 
degradation, other dyes have been explored, which could substitute for FMN. Broad-
hurst [116] and Lopez [115] have separately reviewed a wide a range of different dyes, 
including xanthenes, thiazines, porphyrins and quinones. 
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Photo-CIDNP of Amino Acids and Proteins 
Only three amino acid residues are readily polarisable: tyrosine (Tyr, Y), tryptophan 
(Trp, W) and histidine (His, H). Photo-CIDNP spectra of these residues are shown 
in Figure 2.8. Tyrosine shows a strong emission for the H(3,5) protons and a weak 
absorption for the H(2,6) and /3-CH2 protons. The photo-CIDNP spectrum of tryp-
tophan shows absorption for H(2,4,6) protons on the aromatic ring and emission for 
f3-CH2 protons. Similarly, for histidine we observe absorption for the ring protons 
H(2,4) and emission for /3-CH2. The phases of enhancements are consistent with the 
prediction of Kaptein's rule for the net CID NP effect [110]. 
There are numerous factors that influence the intensity of the CID NP signal in an 
amino acid. Most importantly, photo-CIDNP gives us residue specific information on 
surface accessibility of the polarisable residues, since radical pair formation requires the 
contact of an amino acid side-chain with the photo-excited dye (Figure 2.7B). A failure 
to detect a residue polarisation, however, may not always be due to its inaccessibility 
on the protein surface. Hence, care should be taken in interpreting CIDNP intensities. 
The cancellation process is for example responsible for the dependence of CIDNP in-
tensities on both the pH and the concentration of the amino acid. The photo-CIDNP 
signal intensity dependence on pH has been optimised for N-acetyl tyrosine, N-acetyl 
tryptophan and N-acetyl histidine at pH 4, pH 9 and pH 7, respectively. Intensities 
can depend also on kinetic competition for the photo-excited dyes between different 
amino acid side chains present in a protein. It turns out that tyrosine and tryptophan 
compete much more effectively for flavin triplets than histidine. 
The polarisations of amino acid side-chains are expected to be qualitatively the 
same in a protein environment as those described above for free amino acids, since g-
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Figure 2.8: Photo-CIDNP of Amino Acids: 600 MHz lD 1 H photo-CIDNP (top) and 
NMR spectra (bottom) of the amino acid residues. The aromatic regions are on the left and 
aliphatic part on the right hand side. A. Tyr (4mM, pH 4), B. His (lOmM, pH 7) and C. Trp 
(3mM, pH 9). FMN concentration for all samples was 0.2 mM. All spectra have 16 scans with 
lOOms light flashes. 
values and hyperfine coupling constants do not change significantly. However, the large 
size of proteins and diverse accessibility of different residues causes the magnitude of 
polarisation intensities in the spectra to differ. The slower rotational diffusion in pro-
teins does not only cause cross-polarisation effects (i.e. transfer of polarisation between 
nuclei by cross-relaxation processes) to change sign, but can affect NMR linewidths. 
Photo-CIDNP proved to be a very successful technique for probing protein sur-
face and has three important advantages over conventional NMR spectroscopy: bet-
ter resolution of the residue signals, enhancement of signal intensity and information 
about surface accessible aromatic residues. An example of bovine a-lactalbumin protein 
(BLA) photo-CIDNP is shown in Figure 2.9. The monitoring of surface accessibility has 
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Figure 2.9: Photo-CIDNP of bovine a-lactalbumin: 600 MHz NMR (top) and photo-
CIDNP (bottom) spectra of bovine a-lactalbumin (BLA) (1.5 mM, pH 7.40, 40°C, 0.2 mM 
FMN, 16 scans). The aromatic residues, which are solvent accessible and give the photo-CIDNP 
signals, are denoted on the three-dimensional structure of BLA, made with MolMol (14]. 
been applied through CIDNP in various contexts and examples include protein-ligand, 
protein-micelle, protein-nucleic acid, protein-oligosaccharide and protein-protein inter-
actions. Another alternative application that has received surprisingly little attention 
outside the Oxford CIDNP group (Hore et al), is its application to protein folding. 
Combining the surface accessibility information with the advantages of using photo-
CIDNP as a real-time technique have recently been exploited and several theses and 
articles are starting to appear [113, 114, 115, 117, 118, 119] . 
2.6.3 Experimental methods for NMR and photo-CIDNP 
For a photo-CIDNP experiment, two spectra are recorded, one after the irradiation with 
a light source (light spectrum) and another one without irradiation under the same set 
of conditions (dark spectrum). The difference between the light and the dark spectra, 
called the CIDNP spectrum, shows only those resonances which are perturbed by the 
irradiation, i.e. only protons with appreciable hyperfine couplings in the corresponding 
radicals are polarised. The schematic of the set-up is shown in Figure 2.10. 
All NMR spectra were recorded on home-built 600 and 750 MHz NMR spectrom-
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Figure 2.10: Experimental NMR and photo-CIDNP set-up: Argon ion laser, magnet 
immersed in liquid He and N2 and NMR tube setup with coaxial insert and optical fibre. 
eters (Oxford Centre for Molecular Sciences) with operating frequencies of 600.20 and 
750.02 MHz, respectively. The spectrometers are equipped with Oxford Instruments 
magnets, Omega software and digital control equipment (Bruker Instruments), home-
built triple resonance probe heads and home-built linear amplifiers. For photo-CIDNP 
experiments, the light of a 4 W continuous-wave argon ion laser (Spectra-Physics Sta-
bilite 2016-05) with light pulses of 100 ms was introduced into the NMR tube via an 
optical fibre (diameter 1 mm), inside a coaxial Pyrex insert (Wilmad WGS 5BL). All 
NMR data were processed using Felix 2.3 software from Biosym Technologies. The 
experimental details of simple ID NMR and photo-CIDNP experiments are included 
in the results and discussion chapters with their corresponding figures. 
Two-dimensional NMR spectroscopy 
In order to characterise the tertiary structure of some conformations on the folding 
pathway, 2D COSY and NOESY experiments were done. Here an introduction of 
both techniques is given with schematic drawings of typical pulse sequences for such 
experiments. 
The basis of the 2D COSY experiment is the process of coherence transfer, in 
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which magnetisation is transferred through bonds between coupled spins (Figure 2.11). 
Two radio-frequency nonselective 
t2 
--------···-·-·--------------·-·---·-··--·--···--····-----. pulses are applied, of which the 
preparation 
Figure 2.11: COSY: Homonuclear COrrelated Spec-
troscop Y pulse sequence, 90~ indicates the 90° pulses 
around the x axis, whereas t 1 and t2 are the evolution 
and the observation period, respectively. The FID is 
detected during t2 • 
second is the observation pulse. The 
FID recorded during the detection 
period t2 is influenced by the length 
of the evolution period t1, between 
the two pulses. A second time dimension can be thus created by incrementation of t1. 
For each value of t1 a FID recorded as a function of t2 is stored so that a data matrix of 
s(t1 , t2) is obtained, which after 2D Fourier Transformation produces a 2D frequency 
spectrum S ( w1, w2). The chemical shift information is contained within the diagonal 
peaks, whereas the off-diagonal cross peaks delineate scalar coupling connectivities. A 
single 2D COSY experiment can in theory resolve all scalar spin-spin coupling connec-
tivities between protons in a macromolecular structure. 
The 2D COSY experiment performed on MFI of AAI protein, was done at 
750.01690 MHz spectrometer frequency, with spectral width in both dimensions, w1 
and w2, of 6666.67Hz. The number of points was 1024 in each dimension. The spectra 
in w1 were averaged over 48 acquisitions and 1024 in w2. The delay time between the 
acquisitions was 1.45 s. The protein solution was prepared in a Shigemi tube, in 99.9% 
D20 at pH 7.0. The protein concentration was 1.0 mM. 
A typical 2D NOESYpulse sequence with three radio-frequency pulses is shown in 
Figure 2.12. The effect of the first two pulses is the same as for a COSY pulse sequence 
and the evolution period t1 is similarly incremented to create the second dimension. 
The mixing time, Tm, which separates the second and the third 90~ pulses is of key 
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importance, because it is the time in which the NOE's build up. For large biologically 
relevant molecules in aqueous solution, such as proteins and nucleic acids, the typical 
mixing times range from 50 to 300 ms. The mixing time, Tm, has to be selected so that 
a maximum NOE builds up. There are two competing processes occurring during the 
delay Tm , cross-relaxation from the perturbed spins which causes NOE enhancements 
and spin-lattice relaxation which restores all intensities to their equilibrium values (thus 
destroying NOEs). 
90°, 90°, 90°, 
'tm 
preparation evolution mixing 
Figure 2.12: NOESY: Nuclear Overhauser SpectroscopY 
pulse sequence. 90~ indicate the 90° pulses around the x 
axis, Tm is the mixing period, when the NOE's build up, 
whereas t 1 and t 2 are the evolution and the observation 
period, respectively. The FID is detected during t 2 • 
However, two or several sub-
sequent cross-relaxation steps 
can cause spin diffusion, which 
greatly influences the observed 
NOE intensities and is the most 
common reason for a mistaken 
interpretation of NOESY data. This is why NOE build up experiments are done to 
examine the most suitable Tm value and to prevent the loss or falsification of part of the 
information content of NOESY spectra. Such experiments involve plotting intensities 
of cross peaks for different Tm values. 
The 2D NOESY spectra of native and MFI species of AAI protein were done at 
600.1507820 MHz spectrometer frequency, with spectral width in both dimensions, w1 
and w2, of 8000 Hz. The number of points was 1024 and 512 in w1 and w2, respectively. 
The spectra were zero-filled in the second dimension to 1024 points. The spectra in 
w1 were averaged over 32 acquisitions and 336 in w2. The delay time between the 
acquisitions was 2.0 s. Mixing time, Tm, was set to 200 ms. The experiments were done 
with a Shigemi tube, 1.0 mM protein, 99.9% D20, at pHs: 3.0 and 7.0 . 
Chapter 3 
AAI peptide preparation 
3.1 Introduction 
Protein samples used in biophysical and biochemical studies of protein folding need to 
satisfy two major requirements. First, they should be available in substantial amounts 
of high purity. Second, they need to be ready for use in as short as possible time, 
because they are the starting point of time consuming experiments, which provide 
novel data about the folding phenomena. Solid Phase Peptide Synthesis (SPPS) is a 
technique able to provide several tens or hundreds of milligrams of peptide in a matter 
of several weeks and is therefore extensively used for preparation of peptides and short 
proteins. 
It has been confirmed previously that synthetic AAI peptide from SPPS is able to 
refold in vitro and achieve its biological activity [19]. In the present chapter, the results 
from an improved synthesis approach are presented, which increased the overall yield 
of peptide synthesis and recovered a greater amount of the peptide after the refolding 
step. The details of the experimental strategies are given in Chapter 2, section 2.2.3. 
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3.2 Solid phase peptide synthesis 
3.2.1 Results of AAI peptide synthesis 
It can be anticipated from AAI's primary sequence and predicted by Peptide Compan-
ion software [120] that certain coupling steps in the synthesis would be more difficult, 
for example residues Cysl, Ile2, Lysll, Gly14, Val15, Tyr21 and Tyr27. This was in 
part confirmed, because the introduction of residues Cysl, Ile2 and Lysll required dou-
ble coupling steps. Apart from these residues, seven out of eight N-terminal residues 
required multiple couplings, probably because of the increasing aggregation potential 
· of the growing peptide chain towards the end of the synthesis. Especially difficult was 
residue Lys4, which required a triple coupling. The amino acid derivatives used in SPPS 
of AAI peptide, their molar excesses and the times of coupling steps are summarised 
in Table 3.1. 
The synthetic reaction was monitored during the individual coupling steps. Be-
fore attempting Fmoc-deprotection, Kaiser [92] or chloranil [93] tests were proven nega-
tive for all residues. This confirmed the absence of unreacted amines and the completion 
of the acylation reaction. After the introduction of residues Ser25, Thr22, Cysl 7 and 
Cys8, small amounts of the incomplete peptide were cleaved off from the resin, side-
chains were deprotected and the crude mixtures were analysed with RP-HPLC and 
ESI-MS. The results from this analysis are seen in Figure 3.lA. The four peptides have 
8, 11, 16 and 23 sequential C-terminal amino acids from the AAI sequence, respectively. 
They are all >90% pure and confirm the correct molecular masses. In Figure 3.lB, the 
RP-HPLC profile of the crude, full-sequence AAI peptide is shown. The molecular mass 
of the main peak corresponds to the completely reduced AAI peptide with six cysteine 
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step derivative couplings molar excess time [min] 
1 Fmoc-Cys(Trt )-OPfp 1 1 60 
2 Fmoc-Asn(Trt)-OH 1 4 85 
3 Fmoc-Gly-OH 1 4 110 
4 Fmoc-Tyr(tBu)-OH 1 4 60 
5 Fmoc-Tyr(tBu)-OH 1 4 125 
6 Fmoc-Asp(OtBu)-OH 1 4 120 
7 Fmoc-Ser(tBu)-OH 1 4 60 
8 Fmoc-Thr(tBu)-OH 1 4 60 
9 Fmoc-Cys(Trt )-OPfp 2 1+2 60 + 60 
10 Fmoc-Thr(tBu)-OH 1 4 90 
11 Fmoc-Tyr(tBu)-OH 1 4 45 
12 Fmoc-Pro-OH 1 4 90 
13 Fmoc-Glu( OtBu )-OH 1 4 90 
14 Fmoc-Cys(Trt )-OPfp 1 ~ 120 
15 Fmoc-Cys(Trt )-OPfp 1 ~ 80 
16 Fmoc-Pro-OH 1 4 110 
17 Fmoc-Val-OH 1 4 70 
18 Fmoc-Gly-OH 1 4 60 
19 Fmoc-Asp(OtBu)-OH 1 4 80 
20 Fmoc-Met-OH 1 4 90 
21 Fmoc-Lys (Boe )-0 H 2 4+4 90 + 30 
22 Fmoc-Pro-OH 1 4 90 
23 Fmoc-Gly-OH 1 4 90 
24 Fmoc-Cys(Trt)-OPfp 2 ~+3 120 + 60 
25 Fmoc-Arg(Pbf)-OH 2 4+4 120 + 90 
26 Fmoc-Asn(Trt)-OH 2 4+4 120 + 60 
27 Fmoc-Trp(Boc)-OH 2 4+4 120 + 60 
28 Fmoc-Lys(Boc)-OH 3 3+3+3 120 + 60 + 120 
29 Fmoc-Pro-OH 2 4 120 
30 Fmoc-Ile-OH 2 4+4 120 + 120 
31 Fmoc-Cys(Trt )-OPfp 2 1+4 120 + 120 
Table 3.1: Amino acid derivatives used in solid phase synthesis of AAI: All first 
couplings for cysteine residues (underlined), were done with -OPfp derivatives in the absence of 
base. The second round of couplings for Cys23, Cys8 and Cysl, were done with pre-activation 
with 2,6-dimethylpyridine (DMP) as base. Instead of using 1003 N,N-dimethylformamide 
(DMF), the cysteine couplings were done in CH2 Cb : DMF = 1:1. 
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thiols and its purity was 92.1 %. Both the average yield per synthetic step and the 
overall experimental yield for this SPPS are very high, 99.9% and 92.1 %, respectively. 
The exact quantification and yield calculation are given in Equations 3.1 to 3.10. 
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Figure 3.1: RP-HPLC analysis of partial and complete AAI peptide: A. The four 
partial cleavages of the incomplete AAI synthesis. B. Profile of the crude, complete sequence 
AAI. The amino acid sequences, experimental MW (red) and theoretical MW (black) are written 
next to the main peaks. The profiles were obtained with a RP C18 analytic column (5 µm) and 
a gradient of 0-203 B (5 min) followed by 20-303 B (30 min) at a flow rate of 0.8 ml min- 1 . 
initial resin substitution 0.283 mmol / g (3.1) 
initial resin mass = 2644.7 mg (3.2) 
synthesis scale 0.750 mmol (3.3) 
MR (protected AAI) 6658.5 mg/ mmol (3.4) 
- initial Fmoc-Ser(tBu)-OH on resin 383.5 x 0. 750 287.6 mg (3.5) 
+final peptide weight 0. 750 x 6658.5 4994.3 mg (3.6) 
theoretical yield 7351.7 mg (3.7) 
experimental yield 6767.0 mg 92.1 % (3.8) 
synthetic steps 1 94 (3.9) 
average yield per synthetic step 9V'0.9205 = 99.9 % (3.10) 
1 Three chemical reactions are repeated for each amino acid that is added to the peptide 
chain: deprotection, activation and coupling. An additional step is the Fmoc-deprotection of 
the N-terminal residue. Therefore for AAI, we have 3 x 31 + 1 = 94 steps. This number is 
used for calculation of average yield per synthetic step. 
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The impurities, which constitute "'8% of crude AAI peptide and include mainly 
side products of SPPS and racemised AAI products, were studied by LC-MS and ESI-
MS. Almost 6% of the crude product is constituted by partial deletions of two to five 
sequential amino acid residues, see Figure 3.2B. The deletions are in places of the 
primary sequence that were observed as difficult synthetic points and required multiple 
couplings (Table 3.1). On the basis of a LC-MS experiment (data not shown), it was 
concluded that "'2% of the crude product underwent racemisation. This is a common 
side reaction in SPPS and is for AAI identified by the existence of a peak in the 
chromatogram immediately to the right of the main peak, with the same molecular 
mass. If we assume that racemisation happens mostly at the introduction of cysteine 
residues, this averages at "'0.3% per cysteine residue. This is the expected rate of 
racemisation for cysteines found in the literature (121]. The remaining impurities are 
below 0.5% and include for example the oxidation of methionine residue into methionine 
sulphoxide. 
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Figure 3.2: ESI-MS of crude AAI peptide: A. ESI mass spectrum of the crude AAI peptide 
B. The deconvoluted mass spectrum to show the molecular mass of the crude product, of which 
the RP-HPLC profile was shown in Figure 3.1. The side products of SPPS are identified with 
their molecular masses and the deletions in their sequence. 
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3.2.2 Improvement from previous strategies 
In this section the improvements of the synthetic strategy are summarised with re-
spect to the previously published material [19]. The greatest advantage of the present 
protocol is the substantial yield and purity increase of the crude peptide. 
A major factor influencing the increase in yield is the minimisation of racemisa-
tion at cysteine residues. Racemisation in peptide synthesis is usually a base-induced 
side reaction, which can be prevented at the activation step of the coupling reaction. 
The mechanism of racemisation that is of importance to AAI synthesis is direct enolisa-
tion that occurs at the activation of the cysteine residues for coupling. Deprotonation 
by strong unhindered bases at the a-carbon results in racemisation because the carban-
ion can re-protonate on either side as is schematically shown in Figure 3.3. This is why 
the strong base N,N-diisopropylethylamine (DIEA), used for activation of the coupling 
reactions, was avoided for cysteine residues. It has been observed that racemisation 
is minimised when cysteine residues are introduced as pentafluorophenyl ester (OPfp) 
derivatives in the absence of any base [121]. The choice of OPfp ester was made because 
these derivatives are efficient·acylating agents despite being slow, yielding products of 
high purity in efficient coupling reactions. As an alternative, when cysteines are in-
troduced as free carboxylic acids, a weaker base, 2,6-dimethylpyridine, which has a 
significantly lower pKa value than DIEA (6.7 instead of 11.4), was used. As a result, 
the racemisation rate was successfully minimised to below 2% (averaging at rv0.3% per 
cysteine coupling step) from the previous 17% [19]. 
Another improvement in the strategy was the change in the side-chain protection 
of the cysteine residues from Acm to Trt, which enabled the deprotection and cleavage 
from the resin in one step. This is important because any additional steps in synthetic 
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Figure 3.3: Racemisation through direct enolisation pathway: This mechanistic scheme 
shows the two possible pathways for the attack of carbanion after deprotonation of the a-carbon. 
chemistry can cause product loss and lower overall yield. The Acm protecting group, 
which was used previously [19], requires deprotection with Hg(Ac)2, which results in 5-
10% aggregated (possibly dimerised) peptide. Additionally, the use of heavy metals can 
contaminate laboratory equipment and are noxious in case of environmental diffusion. 
Further, in our synthetic scheme no significant oxidation of the Met5 residue to 
sulphoxide was detected (less than 0.5%), which is usually observed as a peak in the 
mass spectrum with molecular mass increase of 16 Da. This oxidation was prevented by 
the use of an inert atmosphere of N 2 throughout the synthesis reaction. Previously, l"V8% 
of the crude peptide was observed with an oxidised methionine residue [19]. Overall, 
this optimised protocol increased the yield of the product from l"V61 % to 92. l %. 
3.3 Folding and purification 
3.3.1 Optimisation of oxidative refolding 
Disulfide rich proteins, which are either chemically synthesised or obtained from recom-
binant expression, require an additional step in order to oxidise the cysteine residues 
into their native disulfide bonds. Oxidative refolding in vitro requires conditions, which 
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give a balance between the control of aggregation and the formation of the correct disul-
fide bonds. The methods to find the optimum conditions that give a better yield in 
a shorter amount of time are still relatively empirical. A systematic approach, which 
evaluates a matrix of conditions, is preferred. 
The folding process of AAI peptide was studied in order to optimise the yield 
of the native protein recovery after about 20 to 24 hours. The folding conditions that 
were varied included: pH (7.25 to 8.50), AAI protein concentration (20 to 200 mg/I), 
temperature (4°C to 25°C), concentration of denaturant (urea or guanidine hydrochlo-
ride: concentration 0 to 2M) and redox reagents and their ratios ( cysteine/ cystine vs. 
glutathione reduced/glutathione oxidised, ratios 1:20 to 1:5). Apart from the pH value 
and the protein concentration, the conditions that gave the best renaturation yield of 
native AAI were confirmed to be the ones used previously by Lozanov et al [19]. In the 
following section the optimisation of pH value and concentration of AAI peptide are 
described. 
The folding yield was first increased by determining the optimal pH of the oxida-
tive folding buffer (Figure 3.4A). The yield of native AAI protein was compared after 
20h of the folding reaction at various pH values, keeping all other conditions fixed. The 
pH values examined were from 7.25 to 8.50, which is the range of pH values found in 
the literature. The yield increased markedly at higher pH values; from rv60% of native 
AAI being recovered at pH 7.25 rising to over 93% at pH 8.50. Higher pH values were 
not taken into consideration because different phenomena, which are unfavorable for 
the recovery of pure native protein, are present at pH values over 8.50. At pH 8. 70 for 
example, which is known to be close to the pKa of cysteine thiols, a heterogeneous pop-
ulation of intermediates with different ionisation states for different cysteine residues 
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Figure 3.4: Dependence of native AAI recovery on pH and concentration: The 
renaturation yield of the native AAI protein was examined after 20 hours of reaction at different 
pH values (A) and different protein concentrations (B). Panel A represents oxidative folding 
at various pH values at a fixed protein concentration of 100 mg/1, whereas panel B. represents 
experiments at various peptide concentrations at a fixed pH value of 8.50. In both panels a 
graph of renaturation yield versus the changing condition is added for clarity. The remaining 
conditions were as follows: cystine:cysteine=0.05 mM :1 mM, 1.0 M GdnHCl, 0.1 M NH4 0Ac, 
2 mM EDTA, bubbled with N2 
can be detected [41 ]. The free thiols cause fast reshuffiing of the native disulfide bonds, 
hence making the folding reaction more heterogeneous, erroneous and indirectly also 
longer. A particular disadvantage for cysteine containing peptides at high pH values 
is also the possibility of a ,8-elimination reaction, which can take place even at room 
temperature [122]. Another process to consider is racemisation, which can be acceler-
ated at high pH (and high temperature) via the direct enolisation pathway (Figure 3.3) 
even in aqueous solution of deprotected, chirally pure peptides [122]. As a result, the 
pH value of 8.50 was chosen, giving >933 recovery of the native peptide after 20 hours 
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of oxidative folding. 
Further, the maximum amount of protein per litre of refolding buffer was studied 
in order to increase the amount of production of the native protein. In Figure 3.4B, the 
renaturation yield of native protein over 20h of folding is examined as a function of AAI 
concentration. The yield decreases slowly as the concentration is raised from 50 to 100 
mg per litre of refolding buffer, staying >90%. However, at concentrations higher than 
100 mg/I, the renaturation yield is rapidly decreasing as the protein concentration is 
increased, showing a drop to a renaturation yield of just over 80% at 200 mg/I. In order 
to maximise the amount of AAI protein refolded efficiently per litre of refolding buffer 
and to minimise the effects of aggregation and polymerisation, the protein concentration 
was kept at 100 mg/I. 
It is believed that protein concentration in the folding buffer is the main factor 
governing aggregation, which is often the cause of low recovery yields. Folding inter-
mediates tend to aggregate more readily than native conformations through normally 
unexposed hydrophobic regions on their surface. In the kinetic competition between 
folding and aggregation, the latter is favoured at high protein concentration, because 
of its higher reaction rate order, estimated to be ~2.5, whereas folding is usually a 
first order reaction [123]. Also, in a cysteine rich peptide such as AAI, high concentra-
tion may increase aggregation through dimerisation and polymerisation via formation 
of intermolecular disulfides. The inhibition of intermolecular interactions, which are 
responsible for aggregation, with the use of low molecular weight additives is an effi-
cient strategy to increase renaturation yields [124]. The exact mechanism of the action 
of these additives is still unknown. They may influence the solubility and stability of 
the native, denatured and intermediate states, they may act by solubilising aggregates 
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or by changing the ratio of the rates for folding vs. aggregation. AAI peptide does 
not have major aggregation problems, when a small amount of additives is used. It 
was found that 1.0 M GdnHCl and 2mM EDTA were the optimum combination for 
preventing the aggregation in AAI oxidative folding, although other combinations and 
concentrations were examined (data not shown). 
A summary of the final conditions used for the optimised refolding buffer, which give 
a final folding yield >93%, is given below: 
1. AAI protein concentration: 100 mg/I 
2. temperature: 25°C 
3. pH value: 8.50 
4. denaturant: 1.0 M GdnHCl 
5. salts: 0.1 M NH40Ac 
6. redox pair, cysteine / cystine: 1 mM : 0.05 mM 
7. metal chelator: 2 mM EDTA 
8. bubbled with N2: 20 min 
3.3.2 Preparative purification of native AAI 
The scale up process of the refolding protocol at optimised conditions to several hun-
dreds of milligrams gave the same results for the yield of renaturation (>93%). Two 
sets of refolding experiments were done. The first set repeated the same procedure 
of refolding as described by Lozanov et al [19], whereas the second set of experiments 
was done under the optimum refolding conditions, described previously in section 3.3.l. 
Each sets of experiments repeated the folding starting from the crude AAI product and 
the purified reduced AAI, see Figure 3.5. 
In Figure 3.5 the four RP-HPLC profiles of folding mixtures after 20 hours of 
reaction are shown. Interestingly, under the optimum refolding conditions, native AAI 
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Figure 3.5: Preparative AAI refolding: Comparison of RP-HPLC profiles of the folding 
mixtures after 20h: A. folding conditions taken from Lozanov et al (19], B. optimum folding 
conditions, described in section 3.3.1. The blue chromatograms result from oxidative folding 
starting from crude reduced AAI, whereas the purple ones result from purified reduced AAI. 
protein does not regenerate in a considerably greater amount if the starting material 
(reduced AAI) has been previously purified from the crude mixture. The difference in 
renaturation yields is only 2% (Figure 3.5B). Therefore, after the extraction of the crude 
product from ether, no further purification step is necessary before oxidative folding. 
Every additional step in product preparation lowers the overall yield, so elimination of 
an additional purification step which may cause a loss of 10% is favourable over the 
2% lower oxidative folding yield. 
On the other hand, the difference in renaturation yields between folding from 
crude or purified reduced AAI is 8% at the conditions described previously in the 
literature [19]. The main difference between the two folding protocols is a higher pH 
value of the optimum refolding protocol (8.50 versus 7.80). The reason for the greater 
difference in yield in non-optimised conditions could be a lower solubility of impurities 
that are present in crude AAI at the low pH. These species could cause more aggregation 
or promote the formation of non-native disulfides. It should be also noted that a major 
advantage for obtaining higher yields of renaturation described in this chapter was the 
better quality of the starting material, the crude reduced AAI. This is confirmed with 
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a rvl6% increase in refolding yield when the experimental procedure was reproduced 
from (19) with our crude material (bottom chromatogram in Figure 3.5A). 
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Figure 3.6: ESI-MS of native AAI peptide: A. ESI mass spectrum of native AAI peptide 
B. the deconvoluted spectrum on the right. The molecular mass of the product is shown and 
its RP-HPLC profile was shown as the bottom chromatogram in Figure 3.5B. 
After preparative purification and isolation of the main peak on the refolding 
profile, ESI-MS confirmed the mass of the native product, which is shown in Figure 3.6. 
After lyophilisation, a small amount of native AAI was analysed by LC-MS, which 
demonstrated >99% purity. Finally, the disulfide bridge connectivity was proven by 
proteolytic digestion and ESI-MS (see section 4.3 and Table 4.2). The refolded AAI 
was lyophilised and kept at room temperature under a N2 atmosphere and proved to be 
extremely stable, even over longer periods of months. Similarly, the purified reduced 
AAI peptide was also stable when purified and stored for longer periods of time. The 
reason for this inherent stability is also the absence of heavy metal ions, like Hg2+, 
which even in trace amounts accelerate greatly the formation of disulfides, including 
the non-native ones. This can produce insoluble and heterogeneous products, which 
are prone to racemisation and other non-desirable modifications. 
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3.4 Conclusions 
New synthetic and refolding strategies with high yields of native AAI protein were 
developed. The improvement of the SPPS approach increased the yield of crude, re-
duced AAI from the previous value of rv61% to 92.1%. This was done by minimising 
the racemisation at cysteine residues, decreasing the number of steps in the synthetic 
protocol and eliminating almost entirely the oxidation of the Met5 residue. Further, 
the matrix of oxidative folding conditions was optimised to give a maximum refolding 
yield >93%. It was also observed that the high quality of crude reduced AAI allows 
the oxidative refolding step to be started directly from it without further purification. 
The concentration of protein in the refolding buffer was increased, so that about 90 mg 
of purified native AAI protein is recovered per litre of refolding buffer. 
Chapter 4 
Oxidative folding intermediates 
4.1 Introduction 
A nascent linear protein chain has to adopt a series of conformational intermediate 
states before it can reach its native structure. This is why protein folding studies, 
including the ones presented in this thesis, are in part focussed on the detection and 
characterisation of the folding intermediates. One approach to study the intermediate 
states is oxidative folding, where a denatured, reduced, disulfide rich protein is allowed 
to refold in the presence of a redox buffer. In this composite process the protein re-
gains both its native 3D structure and its native disulfide bonds [37]. An important 
attribute of an oxidative folding study is the ability to trap, isolate and hence charac-
terise all disulfide intermediates present on the pathway, since they are covalently sta-
ble species. The intermediate conformations define the folding of a protein in terms of 
their heterogeneity, disulfide content and three-dimensional structures. The technique 
to track the formation and stabilisation of native disulfide bonds was pioneered by 
Creighton [40, 45], who trapped the folding intermediates of bovine pancreatic trypsin 
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inhibitor (BPTI). A further study of the BPTI folding pathway [41] improved this tech-
nique, which now involves acid trapping of disulfide intermediate species that are later 
separated with RP-HPLC. 
A protein that contains three disulfide bridges has 75 different possible disulfide 
isomers, among which is also the native disulfide connectivity. These 75 isomers include 
15 one-disulfide, 45 two-disulfide and 15 three-disulfide species. The starting point of 
oxidative folding is the completely reduced state, with 6 cysteine thiol groups, which 
needs to oxidise into a three-disulfide isomer with the native disulfide connectivity. In 
the present chapter, disulfide intermediate species that appear on the folding pathway 
of Amaranthus a-amylase inhibitor, are identified and characterised in terms of their 
disulfide content and heterogeneity. For five intermediate species, which have three 
disulfide bonds, the disulfide bond connectivities were determined by means of pro-
teolytic digestion and mass spectrometry. Further, three "milestone" species of AAI 
oxidative folding were studied by means of mass spectrometry and circular dichroism 
to compare their molecular masses and molecular structure. As a final section in this 
chapter, a study on vicinal disulfide bonds is included, composed of a database search 
and molecular modelling. 
4.2 Disulfide content of intermediate species 
The folding pathway of AAI protein is very heterogeneous in terms of the content of 
disulfide structures which are present. Altogether, ten species could· be isolated and 
detected in sufficient amount to be studied in terms of their disulfide content. Out 
of these, five species were observed to have one or two reduced cysteine residues and 
two disulfide bonds and the remaining five had three disulfide bonds. The distribution 
4.2. Disulfide content of intermediate species 68 
native~~====:::;-~, I , , I I 8 1718 
8 1718 23 31 
23 31 
0 
20 30 retention time (min] 40 
Figure 4.1: Reversed-phase HPLC separation of intermediate species: Two RP-HPLC 
chromatograms are shown: one is the separation of the folding mixture after 45 min (showing 
a heterogeneous mixture of intermediate species) and the second one after 1 min (showing 
mainly the reduced AAI) of the initiation of folding at the optimum conditions. The emphasis 
is given on the reduced, MFI and native AAI species. Their disulfide structures are drawn 
next to the peaks belonging to the corresponding species. Additionally, the elution positions of 
the remaining fully oxidised (1-1, 1-4, 1-5, 1-6) and partially oxidised (P-1, P-2, P-3, P-4, P-5) 
intermediates are shown. 
of fully oxidised (three-disulfide) intermediates (denoted with I) and partially reduced 
species (denoted with P) when separated with RP-HPLC is shown in Figure 4.1. At 
least four species on the folding pathway were detected to bind an exogenous cysteine 
molecule. In partially reduced species cysteine sometimes remains attached, because it 
is the reducing agent in the refolding buffer, which drives the isomerisation of non-native 
disulfide bonds (via thiol-disulfide exchange mechanism). 
All ten intermediate species were first isolated and purified and then two separate 
experiments were done on each of the intermediate species in order to determine the 
number of disulfide bonds and free cysteine residues. First a simple molecular weight 
determination by LC-MS system was carried out, followed by an experiment involving 
iodoacetamide modification with subsequent LC-MS analysis. The results for molecular 
weights from both experiments are shown in Table 4.1. 
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mol. weigth (Da) exogenous 
species LC-MS after C.M. disulfides free thiols cysteine 
native 3586.2 3586.1 3 0 no 
MFI 3585.9 3586.1 3 0 no 
P-1 3587.9 + 120.5 3702.5 2 1 or 2 yes 
I-1 3586.3 3586.2 3 0 no 
P-2 3588.4 + 120.5 3701.5 2 1 or 2 yes 
I-4 3586.2 3586.2 3 0 no 
P-3 3587.8 + 120.5 3702.7 2 1or2 yes 
P-4 3588.4 + 120.4 3701.5 2 .1or2 yes 
I-5 3586.4 3586.1 3 0 no 
P-5 3588.4 3703.5 2 2 no 
I-6 3586.5 3586.8 3 0 no 
Table 4.1: Disulfide bond content of intermediate species: all significantly abundant 
intermediate species were first subjected to an LC-MS analysis of their molecular weight (see 
"LC-MS" column). Later, they were carboxymethylated with iodoacetamide and analysed again 
with LC-MS (see "after C.M." column). In some species, exogenous cysteine was observed. Both 
analyses were done with a micro-bore C-18 column (3.5 µm) and a gradient of 0-203 B in 5min, 
followed by 20-273 B in 30min. The MS data were obtained at orifice +30 V in the positive 
ion mode. 
Oxidative folding pathways should be distinguished and defined both in terms of 
heterogeneity, stability, structure and kinetics of disulfide folding intermediates on one 
hand and in terms of the developments in the three-dimensional conformations on the 
other hand. A complex diversity among oxidative folding pathways has been observed. 
For the model protein BPTI, for example, only one- and two-disulfide intermediates 
with native disulfides and native-like tertiary structures were observed [40, 41]. On the 
other hand, Chang and co-workers studied extensively the oxidative folding mechanisms 
of three-disulfide proteins and defined various distinctive mechanisms, which should 
reflect the distinctive ways the native disulfide bonds in proteins are stabilised [56]. 
One group of proteins sharing a common mechanism includes hirudin [47], tick anti-
coagulant protein (TAP) [52] and potato carboxypeptidase inhibitor (PCI) [49, 50]. 
Dissimilarly to BPTI, these proteins have an oxidative folding mechanism with a high 
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heterogeneity of one- and two- and three-disulfide intermediates. The presence of three-
disulfide species with non-native disulfide bonds is also a characteristic of this mech-
anism. In these proteins, there is also no evidence for predominant intermediates, 
which is on the other hand the case for epidermial growth factor (EGF) [47, 53], whose 
oxidative folding pathway rests between that of hirudin and BPTI. EGF's pathway 
comprises both of three-disulfide isomers like the one of hirudin as well as of a limited 
number of one- and two-disulfide intermediates, one of which is the predominant inter-
mediate with two native disulfides (EGF-II). There have been other proteins like EGF, 
where the predominant intermediate is only partially oxidised and contains only native 
disulfide bonds (usually one less than the native protein), for example hen egg white 
lysozyme (HEWL) [63], EETI-II [125], the cyclotide kalata Bl [73] and insulin-like 
growth factor-I [69]. 
Putting the oxidative folding mechanism of AAI into perspective with other pro-
teins, it is clear that it bears a significant resemblance to other small, three-disulfide 
proteins, such as for example the cystine-knot PCI. AAI presents a pathway with a high 
heterogeneity of one-, two- and three-disulfide intermediates, including fully oxidised 
intermediates involving only non-native disulfides. At the same time it clearly has an 
intermediate species, which prevails in abundance and has therefore been termed the 
main folding intermediate, MFI. This intermediate, dissimilarly to EGF, HEWL and 
others, is fully oxidised and contains three non-native disulfides. 
4.3 Disulfide bonds in three-disulfide species 
For a three disulfide bridge protein such as AAI, there are 15 possible disulfide arrange-
ments with three disulfides, but only one of these combinations represents the native 
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protein pairing. Disulfide intermediate species, which have all cysteine residues oxidised 
are in some way off-pathway intermediate species. They all possess at least two disulfide 
bonds, which do not appear in the native species, hence termed non-native disulfides. 
The non-native disulfides have to undergo reduction before the correct cysteine residues 
pair into the native bonds. Some of these species are extremely abundant and can be 
thought of as an energy well on the protein folding energy surface, into which a certain 
activation energy needs to be put in to convert it to a partially reduced species able to 
further oxidise into the native disulfide bonds. 
On the folding pathway of AAI, five species apart from the native protein have 
three disulfide bonds: MFI, I-1, I-4, I-5, I-6 (see Figure 4.2). These species were 
digested with trypsin and a-chymotrypsin simultaneously and the resulting fragments 
were separated and analysed by LC-MS. The masses and disulfide connectivities of the 
resulting fragments are given in Table 4.2. The disulfide connectivity of the native 
AAI protein was confirmed to have an abc abc topology as noted previously [20]. The 
disulfide bonds of the remaining five species were determined and the comparison of 
these is shown in Figure 4.2. 
The two adjacent cysteines (Cysl 7 and Cys18) in the primary sequence of AAI 
and the absence of a specific reagent, which cuts between two sequential cysteine 
residues is the reason that it is sometimes impossible to distinguish between two com-
binations of disulfide bond topologies. This is the case for I-1 and I-4 species for which 
two topologies are noted in last column of Table 4.2 and in Figure 4.2. Interestingly, 
three species contain the vicinal disulfide bond Cysl 7-Cys18 and it seems this is the 
first time that an oxidative folding intermediate has been discovered with such a fea-
ture. This is why section 4.5 is dedicated to a discussion of the structural features 
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SPECIES FRAGMENT MOLECULAR WEIGHT DISULFIDE 
experimental (charge) theoretical 
[1-5] + [12-21] + [29-32] 2134.5 (1+) 2136.2 1-17 and 18-31 1068.8 (2+) 1068.3 
[1-4] + [12-21] + [29-32] 1948.8 (1+) 1948.3 or N 974.5 (2+) 975.2 1-18 and 17-31 
[8-11] + [22-27] 1090.7 (1+) 1091.2 8-23 545.8 (2+) 546.1 
[1-4] + [8-11] 861.8 (1+) 862.1 1-8 
MFI [22-27] + [29-32] 1066.5 (1+) 1067.1 534.0 (2+) 534.1 23-31 
[22-32] 1211.5 (1+) 1211.3 
[12-21] 1111.8 (1+) 1112.3 17-18 
[1-4] + [8-11] + [12-21] 1972.3 (1+) 1973.4 
987.0 (2+) 987.2 1-17 and 8-18 
I-1 658.3 (3+) 658.5 or [1-5] + [8-11] + [12-21] 1080.0 (2+) 1080.8 8-17 and 1-18 
720.3 (3+) 720.9 
[22-32] 1212.5 (1+) 1213.3 23-31 
[8-11]+ [12-21]+ [22-27] 1100.8 (2+) 1101.8 
[8-11] + [12-27] 2184.3 (1+) 2184.5 8-17 and 18-23 1092.3 (2+) 1092.8 
728.8 (3+) 728.8 or 8-18 and 17-23 
I-4 [8-27] 1083.3 (2+) 1083.8 [1-4] + [29-32] 837.5 (1+) 838.0 
[1-5] + [29-32] 1023.8 (1+) 1025.2 1-31 
[1-4] + [28-32] 1000.8 (1+) 1002.2 
[12-21] 1111.8 (1+) 1112.3 17-18 556.3 (2+) 556.7 
I-5 [1-4] + [22-27] 1146.8 (1+) 1147.3 574.0 (2+) 574.2 1-23 
[1-7] + [22-27] 802.8 (2+) 803.4 
[8-11] + [29-32] 781.5 (1+) 781.9 8-31 
[1-4] + [29-32] 837.5 (1+) 838.0 1-31 [1-5] + [29-32] 1023.8 (1+) 1025.2 
I-6 [8-11] + [22-27] 1090.5 (1+) 1091.2 8-23 546.0 (2+) 546.1 
[12-21] 1111.8 (1+) 1112.3 17-18 556.3 (2+) 556.7 
Table 4.2: Proteolytic digestion of three-disulfide species: native AAI protein and 5 
intermediate species were isolated by quenching the oxidative folding reaction after 30, 35, 40, 
45 or 1200 min by acidification to pH rv2 with 4% TFA and separated by RP-HPLC. Over 98% 
pure species were incubated at 37°C in 0.1 M NH4 0Ac solution at pH 5.2 for 44 h. The ratio 
of trypsin : a-chymotrypsin : protein was 1:1:20. The reaction was quenched with 4% TFA 
and the proteolytic fragments were subjected to analysis on a LC-MS system with a micro-bore 
C-18 column (3.5 µm), applying a gradient of 0-60%B (60 min) at a flow rate of 40µ1 min-1 . 
For some species, the two possible disulfide connectivities are given in the last column. 
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native CIPKWNRtGPKMDGVP6CEPYTCTSDYYGN~S 
n 
MFI CIPKWNRCGPKMDGVPCCEPYTCTSDYYGNCS 
I-1} CIPKWNRtGPKMDGVPCtEPYTCTSDYYGNCS 
1-1 CIPKWNRCGPKMDGVPCCEPYTCTSDYYGNCS 
I-4} CIPKWNRCGPKMDGVPCCEPITCTSDYYGNCS 
1-4 tlPKWNRbGPKMDGVPd2EPITtTSDYYGNCS 
1-5 CIPKWNRCGPKMDGVP£EPITtTSDYYGNCS 
1-6 CIPKWNRtGPKMDGVP~EPITtTSDYYGNCS 
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Figure 4.2: Disulfide bonds in three-disulfide species: a summary and a comparison 
of all disulfide bonds, which appear in three-disulfide species of AAI protein. Apart from the 
native protein, which was confirmed to have the abc abc topology, the prevailing disulfide bond 
appearing in three different species, is the vicinal disulfide bond Cysl 7-Cys18. For I-1 and I-4 
the two possible arrangements are shown. 
that a vicinal disulfide bond can induce and to the comparison of the existing protein 
structures in the Protein Data Bank with this feature. 
On the other hand, it is interesting to examine which intermediates have one 
disulfide in common, because this means they are only one redox step away2 from 
each other on the folding pathway. I-6 is the only species that has a native bond 
(Cys8-Cys23), which suggests that this species is one of the closest (in folding time and 
energy) to the native protein. Three other intermediates share one disulfide exactly 
with the I-6 species: MFI and I-5 have the vicinal disulfide Cysl 7-Cys18 and I-4 shares 
Cysl-Cys31. I-6 could therefore be a "funnelling" intermediate, since it is the species, 
which shares disulfides with the biggest number of species. I-1 is the only fully oxidised 
species, which does not share a disulfide with I-6. It is possible that I-1 has a native 
2To get for example from MFI to 1-6, the bridge 17-18 is retained, while the connectivities 1-8, 23-31 
are swapped for 1-31, 8-23. Where only one such swap occurs and one disulfide bond is retained, the 
species are considered to be one redox step away. 
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disulfide, Cysl-Cys18, but this was not possible to confirm because of the ambiguity of 
the digestion strategy. I-1 also shares one disulfide with MFI (Cys23-Cys31) and could 
be connected to I-6 through this intermediate. More discussion on the kinetics of AAI 
folding is included in Chapter 6. 
4.4 Three "milestone" species on the folding pathway 
Three disulfide arrangements of AAI protein appear consecutively on the oxidative 
folding reaction and dominate each at a different point. At the start, the completely 
reduced peptide (R) with six thiol groups folds rapidly into a heterogeneous mixture 
of intermediate species. Soon after, a second species accumulates to over 30 % (at 
optimum folding conditions) and prevails over all other intermediates in abundance, 
which is why it was termed the main folding intermediate (MFI). The third species is 
the native (N) species with its native three-dimensional structure and disulfide pairing, 
which reaches its maximum abundance at the end of the folding reaction. These three 
species can be seen as the principal three milestones of AAI oxidative folding. 
These three characteristic species are strikingly different in their cysteine residue 
pairings (see sections 4.2 and 4.3). The reduced species has no disulfide bonds, since it 
is the starting point of oxidative folding. The native protein was confirmed to involve 
a cystine knot motif, whereas MFI has disulfide bonds between cysteines, which are 
closest to each other in sequence, also called a "bead-like" structure. 
These prominent species were subjected to a RP-HPLC study in order to deter-
mine their retention times, which would allow easy identification in further analytical 
HPLC studies (Figure 4.1). The three species were well separated (N, MFI and R eluted 
at 19, 24 and 35 min, respectively) with a linear HPLC gradient (20-27% Bin 30min). 
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The retention time is a good indicator of the hydrophobicity. The most hydrophilic 
species is usually and in the case of AAI the native protein. This is to be expected, 
because it possesses both 6 oxidised cysteine residues and its three dimensional scaffold 
has optimised the shielding of hydrophobic groups from the solvent as is usual for native 
structures. The second most hydrophilic is MFI, because the three disulfide bridges 
with respect to the six thiol groups in R make a considerable difference in solvation 
energy. 
Mass spectrometry of N, MFI and R 
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Figure 4.3: ESI-MS spectra of native, MFI and reduced AAI species: All three 
experiments were done in positive ion mode at orifice +40 V. The m/z ratio of each peak in 
the mass spectra is shown next to it and the molecular mass for each species is shown in the 
top left corner insert. BioMultiView software was used for deconvolution of the spectra. 
The reduced, MFI and native AAI states were studied with ESI-MS to determine 
their molecular masses. The experiments were done in positive ion mode at pH 2, where 
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the species are invariably stable in terms of their disulfide content. At this low pH value 
the API ESI-MS instrument has a higher sensitivity and the basic groups in the protein 
are more readily protonated. In Figure 4.3 the ESI-MS spectra are shown, together with 
their deconvoluted spectra, which determine the molecular masses of the three species. 
The masses obtained are in excellent agreement with their theoretical values (for N 
and MFI 3586.2 Da vs. theoretical 3586.l Da and for R 3592.3 Da vs. theoretical 
3592.2 Da). Experiments were done at a variety of ionising conditions, but the MS 
spectra of the three species always appear very similar in terms of the distributions of 
the charge states. This is probably because in a such a small protein even the most 
compact conformation, the native protein, has most or all of the groups, which can be 
protonated, solvent exposed and therefore prone to ionisation. The four charge states 
in AAI protein observed at low pH (data not shown) are due to protonation on three 
side chain NH2 groups (Lys4, Lysll and Arg7) and Na of the N-terminus. The +4 
ionisation state was observed only at lower orifice values (15 to 40 V). 
Circular dichroism of N, MFI and R 
To be able to say more about the secondary and tertiary structure content, CD spectra 
(Figure 4.4) of the native, fully reduced and MFI state were compared both in the 
far-UV and the near-UV region. In the far-UV region (190-260 nm), the CD spectra 
of the reduced and the MFI species are very similar to the characteristic random coil 
state without significant secondary structure. The native state, on the other hand, has 
a non-random coil structure, although it does not show many properties of a ,8-sheet 
protein. This is probably because such a small protein has very short ,B strands ( 4 or 5 
residues in each of the three anti-parallel strands). On the other hand, in the near-UV 
4.4. Three "milestone" species on the folding pathway 
0 ,--~~~~~~~~~-----=:::::;::~~!!!!!!! 
--=o 
~ 
~ -2000 
"Oil 
Qj 
""'d 
~-4000 
~ 
© 
.-.. 
-6000 
-8000 
l 0 
~~ 
w -100 
"Oil 
:! 
-200 ~ 
© -300 
-400 
-500 
200 220 240 260 
wavelength (nm] 
-600+-~~~--.~~~~.,...--~~~-.--~~~--J 
240 260 280 300 320 
wavelength (nm] 
77 
Figure 4.4: Far-UV and near-UV circular dichroism spectra of native (blue), MFI 
(green) and reduced (red) AAI species. The spectra were acquired with 1 nm step resolution, 
50 nm min-1 speed, 1 second response time, 1 nm band width, 20 milli-degree sensitivity and 
16 acquisitions. Cuvettes with 0.2 mm and 1.0 mm path-length were used in the far-UV and 
near-UV region, respectively. AAI protein concentration was 0.1 mM and 2 mM in the far-UV 
and the near-UV regions, respectively. The spectra were acquired at pH 7.0 and 25°C. 
region (260-320 nm), the native and the MFI species had quite similar spectra, while the 
reduced showed again very little intensity, due to its random-coil like structure. These 
results indicate that in reduced AAI state there is an absence of regular structure. MFI 
possesses a disordered backbone, without a significant secondary structure content. At 
the same time, some of its aromatic side chains are constrained and together with the 
three disulfide bonds, this gives a near-UV CD spectrum, similar to the native state. 
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4.5 Vicinal disulfide bridges 
s As mentioned earlier, three species (MFI, I-5 and I-
6) appear to be the first observed oxidative folding 
intermediates possessing a vicinal disulfide bond. 
This is why this section is dedicated to the study 
N of vicinal disulfide bonds, their structural features 
Figure 4.5: Vicinal disulfide and the existence of proteins with this feature in 
bridge: a schematic representation 
of this structural feature made with 
Molmol software [14). The backbone 
bonds are drawn in red and the side 
chains in blue. The disulfide bond is 
emphasised in yellow. 
the Protein Data Bank. 
A vicinal disulfide bridge is a rare structural motif, 
represented by an eight-membered ring, composed 
of the main and side chain atoms of two adjacent cysteine residues (see Figure 4.5). 
Disulfide bridges usually link sequentially distant parts of polypeptide chains. It is 
therefore surprising to find covalent bonds between side chains of neighboring cysteine 
residues in some native proteins that have been structurally characterized (Figure 4.6). 
It can be anticipated that these rare structural motifs have a structural and/or func-
tional role. 
The Protein Data Bank was searched for experimentally determined protein 
structures containing two sequential cysteine residues. There are at present 18 pub-
lished structures, where the two cysteines are oxidised into a vicinal disulfide bridge. 
It is a relatively rare structural element, so far observed in seven different types of pro-
teins. They include bacterial redox enzymes, acid-base enzymes from bacteria, yeast, 
and mammals, plant insecticidal toxins and fish and molluscan receptors involved in 
signal transduction. Seven representative structures, each for one type of protein, are 
shown in Figure 4.6. They are J-Atracotoxin from Hadronyche versuta [126], methanol 
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dehydrogenase from Methylobacterium extorquens [127, 128, 129, 130, 131], the ethanol 
dehydrogenase from Pseudomonas aeruginosa [132, 133], acetylcholine-binding protein 
(AchBP) from Lymnaea stagnalis [134, 135], thioesterase I from Bos taurus [136, 137], 
carboxypeptidase T from Thermoacinomyces vulgaris [138) and anti-microbial peptide 
hepcidin-25 from Homo sapiens [139) (Figure 4.6,A-G). 
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Figure 4.6: Vicinal disulfide bonds in the Protein Data Bank: Schematic view of the 
vicinal disulfide bonds, which have been structurally characterised. Under each structure the 
code of the Protein Data Bank file, which was used to make the image is written. A) ldlo: 
J-Atracotoxin (Hadronyche versuta): C13-C14; B) leh5: palmitoyl protein thioesterase I (Bos 
taurus): C45-C46; C) lflg: ethanol dehydrogenase (Pseudomonas aeruginosa): C105-C106; 
D) lib9 acetylcholine-binding protein, AchBP (Lymnaea stagnalis): C187-C188; E) lobr: car-
boxypeptidase T ( Thermoactinomyces vulgaris ): C155-C156; F) 4aah: methanol dehydrogenase 
(Methylobacterium extorquens): Cl03-Cl04; G) lm4f: hepcidin-25 (Homo sapiens): Cl3-Cl4; 
H) computer model of MFI: Cl 7-Cl8 (see section 5.6). 
On the other hand, there are at least 62 resolved structures, which include two 
sequential cysteines in a reduced form. If the structures of all octapeptides that contain 
two sequential cysteine residues are superimposed, a clear difference between the ones 
containing the reduced and the oxidised form is seen [140). The ones containing the 
oxidised Cys-Cys pair are clearly bent and the two cysteine side-chains protrude on the 
same side of the backbone. On the contrary, protein segments that contain adjacent 
cysteines in the reduced state, possess an extended backbone and the sulfhydril side-
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chains tend to be on opposite sides. The oxidized segments also seem to be more 
constrained than the reduced structures. 
In the past, the conformational analysis of the oxidized Cys-Cys dipeptides 
suggested that the ring might lead to a turn when found in the middle of a pep-
tide chain [141, 142, 143, 144, 145, 146]. The analysis of model peptides confirmed 
that the formation of the vicinal disulfide bond is accompanied by the appearance 
of a tight, ,8-type turn, and this phenomenon is also used in rational peptide de-
sign [126, 130, 131, 147]. The overall stereochemical features of the eight-membered 
heterocycle containing the disulfide bond of the structures in Figure 4.6 appear to be 
close to those observed in Ac-ox-[Cys-Cys]-NH2 [148]. 
A systematic comparison was made between experimental and computational 
data on vicinal disulfide bridges in proteins and peptides [149]. It was found that the 
ox-[Cys-Cys] unit is able to accept types I, II, VIa, Vlb and VIII ,8-turn structures, 
while without the vicinal disulfide bridge the Cys-Cys sequence unit is not constrained 
to form a turn. This is clearly seen in Figure 4.6, where all the protein backbones of 
the proteins containing a vicinal disulfide form a more or less tight turn. At the same 
time, the computer model of the main folding intermediate of AAI (see section 5.6) 
is shown for comparison in Figure 4.6H and it shows the possibility for a similar turn 
in the region of vicinal cysteine residues 17 and 18. The structural features are well 
conserved amongst the proteins reported in Figure 4.6, although the topology of the 
turn is much less conserved than in the case of model peptides. 
The results may be useful in protein engineering, modelling, and design. It is 
also worth noting the possibility of using the redox-regulated transition from turn to 
extended conformation in nano-technology. The turn induced by the oxidation of two 
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adjacent cysteine side-chains, brings the residues preceding and following the Cys-Cys 
pair closer to each other. This fact could be used to construct spectroscopic probes, 
which would give redox-dependent signals. It is worth noting the recent study by 
Park et al [150], where the activity of ribonuclease A has been modulated through the 
insertion of two vicinal cysteines, which can be reversibly oxidized and reduced. 
The biochemical relevance of vicinal disulfides is characterized in detail only for 
a few proteins, but little insight has been obtained about their role at the molecular 
level. Vicinal disulfide bonds can have both a structural role, by stabilizing the local 
backbone conformation, or a redox role, by allowing or assisting the electron transfer. 
In quinoprotein alcohol dehydrogenases [129, 128, 127, 132] and atracotoxin J-ACTX-
Hvlc [126] the vicinal disulfide is proved to be essential for biological activity by site-
directed mutagenesis studies. The atracotoxin J-ACTX-Hvlc, for example, keeps its 
three-dimensional structure unchanged after reduction of its vicinal disulfide bond, 
although its neurotoxic activity is completely lost. A vicinal disulfide bond is supposed 
to be a significant feature in the function of hepcidin, a polypeptide involved in iron 
uptake in the human intestine and iron release in macrophages [139]. The disulfide 
ring is also believed to be necessary in binding and reducing the cation in mercuric ion 
reductase [151 ]. 
4.6 Conclusions 
The complex oxidative folding pathway of AAI peptide is very heterogeneous in terms 
of the disulfide content of its intermediate species. one-, two- and three-disulfide species 
are created as the reduced protein is allowed to refold to its native conformation. The 
three milestones of the folding pathway are identified to be the reduced, the MFI and 
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the native species. The most abundant intermediate species, MFI, has no significant 
secondary structural features, but seems to have some similarity in the orientation of the 
aromatic side-chains to the native protein. Non-native disulfides are formed in five fully 
oxidised intermediate species. One type of non-native disulfide, which has previously 
not been found in oxidative folding intermediates, is present in all three combinations 
that are theoretically possible. This is the vicinal disulfide between cysteines 17 and 
18, which is found in MFI, I-5 and I-6, and is a surprisingly abundant feature of AAI's 
pathway. Vicinal disulfide bonds are found in at least seven wild type proteins, for 
which structures have been deposited in. the Protein Data Bank. Structurally, such a 
disulfide is a turn inducing feature and is also thought to have an important functional 
role in several existing proteins. Some results from this chapter have been recently 
accepted for publication [140, 149]. 
Chapter 5 
Structural studies of MFI 
5.1 The main folding intermediate 
The main folding intermediate (MFI) was named this way, because it is the most 
abundant species on the oxidative folding pathway of the AAI protein. This does not 
necessarily mean that MFI is the kinetically the most important or most productive 
species, a question which will be addressed in Chapter 6. The interesting question to 
ask is what kind of 3D conformation does a species with three non-native disulfides 
adopt. Does MFI's disulfide pattern, the so-called "bead-like" arrangement with_ a 
vicinal bridge, have a specific 3D fold, similar or dissimilar to the native protein? 
Some data about MFI's structure have been obtained with circular dichroism in 
Chapter 4, which indicated that MFI does not have any secondary structure, but has 
some similarity to the native protein in the tertiary orientation of aromatic residues. 
The present chapter will deal with a more detailed structural characterisation of MFI's 
structure with NMR, photo-CIDNP and computer modelling techniques. Most results 
from this chapter have been recently published [152]. 
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5.2 1H NMR and photo-CIDNP spectroscopy 
The first step to elucidate MFI's three-dimensional structure was to compare one-
dimensional NMR and photo-CID NP spectra of the MFI and N species. The similarity 
of the circular dichroism spectra in the near-UV region suggest that some of the ter-
tiary structure of the .two species is similar. NMR spectroscopy was used to obtain 
information about the general conformational similarity and photo-CIDNP spectra to 
compare the accessibility of the aromatic residues and to try to assign the MFI NMR 
spectrum. 
A detailed assignment of the MFI spectrum was done mainly with a 2D COSY 
experiment (section 5.3). However, a few guesses could be made on the basis of the 
multiplet patterns and phases of the amino acids peaks in the photo-CID NP spectrum. 
For example, it was seen in Figure 2.8 that tyrosine H(3,5) doublet is the only emissive 
peak, which appears in the aromatic region of 1 H photo-CID NP spectra. This led to 
the assignment of the region between 6.7 and 6.9 ppm in the MFI spectrum. 
The lD 1 H NMR spectrum of the purified MFI species (Figure 5.lA) resembles 
that of the N state: the chemical shifts are well dispersed and some of the lines are sharp, 
but the MFI-spectrum is clearly more complex. In addition to the major resonances, 
many of which have obvious counterparts in the spectrum of the N state, there are 
several weaker and broader signals close to the principal tyrosine and tryptophan lines. 
This is clearer in the lD 1 H 750 MHz spectrum, where these additional signals, probably 
arising from minor conformations, are better resolved and denoted by asterisks (bottom 
panel in Figure 5. 2). 
AAI contains four aromatic residues (Trp5, Tyr21, Tyr27, Tyr28) whose photo-
CIDNP spectra at pH 7 are compared in Figure 5.lB for N and MFI species. The 
5.2. 1 H NMR and photo-CID NP spectroscopy 85 
N spectrum is well-resolved, with chemical shifts characteristic of a single well-defined 
tertiary structure. The pattern of photo-CIDNP effects indicates that Trp5, Tyr27 and 
Tyr28 are exposed, but that Tyr21, which is not polarized and showed no photo-CIDNP 
signal, exists in a more crowded environment. 
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Figure 5.1: 600 MHz lD 1H NMR and photo-CIDNP spectra of native and MFI: 
A. NMR and B. photo-CIDNP spectra of the purified native state (N) and of the main folding 
intermediate (MFI) (0.3 mM protein, 0.2 mM FMN, pH* 7.0, in D20 at 25°C). NMR and 
photo-CIDNP spectra were recorded with 512 and 16 scans, respectively. The assignments of 
the native state tyrosine resonances are taken from (20]. The tyrosine resonances of the MFI 
species, labelled YA , YB, and Y c, have not been assigned to specific residues. pH* is the 
measured pH of a D2 0 solution, uncorrected for the deuterium isotope effect. 
This result is consistent with the static accessibilities calculated from the three-
5.3. Assignment of NMR spectrum for MFI species 86 
dimensional structure of AAI [153]. The NAccess programme gives relative accessibility 
of each residue calculated as the % accessibility compared to the accessibility of that 
residue type in an extended Ala-X-Ala tripeptide. The relative values for side chain 
atoms of the aromatic groups are expressed for all experimentally calculated structures 
given in the file of the Protein Data Bank. The average accessibility values of the 
ten structures in the lqfd file (NMR structure of the free AAI peptide, [20]) for 'frp5, 
Tyr21, Tyr27 and Tyr28 were 14.4, 2.4, 10.9 and 41.38, respectively. This means that 
the most exposed residue is Tyr28 and the least exposed Tyr21. This result indicates 
that signals in a photo-CIDNP spectrum will probably not be seen from Tyr21, which 
agrees with the experimental data. 
The corresponding photo-CIDNP spectrum of MFI has enhanced signals from 
'frp5 and all three tyrosines; presumably the constraints on the backbone fold imposed 
by the non-native disulfides, allow the exposure of the side chain of Tyr21, itself in 
close proximity to the vicinal disulfide. Additionally, some of the subsidiary lines are 
also polarized, suggesting that the minor conformation(s) also possess similar exposure 
of aromatic residues. 
5.3 Assignment of NMR spectrum for MFI species 
In order to better resolve and to assign the peaks in the aromatic region of the spec-
trum of MFI, a two dimensional homonuclear 1 H COSY ( COrrelated Spectroscop Y) 
experiment was done. The experiment was performed at 750 MHz to obtain better 
resolution in the spectrum. In fact, if we compare the one dimensional spectra at 600 
and 750 MHz, the difference in resolution is clear (see Figure 5.2). As noted before 
there are some smaller, broader peaks, probably belonging to minor conformations. 
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Figure 5.2: ID 1 H NMR spectra of MFI species at 600 MHz (upper spectrum) and 750 
MHz (lower spectrum): the comparison of the two ID spectra in the aromatic region, which 
consists of peaks from Tyr21, Tyr27, Tyr28 and Trp5 residues. The conditions of the two 
experiments were identical. MFI was dissolved at 1.0 mM concentration in D2 0, pH* 7.0, 
25°C. Both spectra are averaged over 64 acquisitions, have 4096 points and were acquired with 
a 12500 Hz sweep width. The delay time between each acquisition was 1.8 s. It is clear that the 
750 MHz spectrum is better resolved and the asterisk denotes peaks , which probably belong to 
minor conformations and were not resolved at 600 MHz. 
In the 2D homonuclear 750 MHz COSY experiment on MFI species (Figure 5.3) 
the cross peaks in the aromatic region were partially assigned. The MFI aromatic 
spectrum was assigned with the help of photo-CIDNP experiments, which can be seen 
in Figure 5.1. Because a full sequential assignment was not possible from the NOESY 
spectra (see section 5.4), the three tyrosine residues were not distinguished from each 
other. The assignment procedure was done by first recognising the specific patterns of 
peaks (belonging to either a Tyr or a Trp residue), followed by linking the diagonal 
peaks to the off-diagonal peaks. 
It was revealed that the signal from the H(2 ,6) protons of one of the tyrosine 
residues ("YA" ) has moved "'0.3 ppm from its position in the spectrum of the na tive 
5.3. Assignment of NMR spectrum for MFI species 
7.2 
. 
0 {') 
(i)C:) 
0 0 
I Yc(H3,H 
~ <!} 
7.0 
YA(H3,H5) 0 
6.8 1 H [ppm] 
88 
6.8 
7.0 
7.2 
Figure 5.3: 750 MHz 2D COSY of MFI species: This section of the aromatic region 
shows mainly H(2,6) and H(3,5) protons of the three tyrosine residues Y A,Y B, Y c and some 
protons from Trp5. The spectral width was 6666 Hz, with 1024 complex points in both direct 
and indirect dimensions. Purified MFI was dissolved at LO mM concentration in D2 0, pH* 
7.0, 25°C. 
state (7.0 - 7.2 ppm), to overlap with the H(3,5) resonances. This chemical shift, which 
gradually increased when the temperature was lowered to 4°C (data not shown), may 
arise from stacking of aromatic side-chains permitted by a changing backbone fold in the 
MFI-state. Closer inspection of this portion of the spectrum (6.7 - 6.9 ppm) revealed 
at least two weak doublets (denoted by an asterisk in Figure 5.2) in addition to four 
strong resonances: the three labelled H(3,5) signals and the shifted H(2,6) peak. The 
cross peaks in the two-dimensional COSY spectrum are surrounded by small, "satellite" 
cross peaks, which belong to the minor conformation(s) (Figure 5.3). 
5.4. Tertiary structure comparison of N and MFI 89 
5.4 Tertiary structure comparison of N and MFI 
The spectrum of MFI was partially assigned in its aromatic region by means of photo-
CIDNP and 2D COSY experiments, and from lD NMR spectroscopy it proved to 
have reasonably similar characteristics to the native protein. Attempts were made to 
determine the atomic resolution structure of MFI using 2D 1 H NMR spectroscopy via 
1 H-1 H nuclear Overhauser effects (NOE) which reveal pairs of protons separated by 
less than rv5 A. The principal experiment in such a process is two-dimensional Nuclear 
Overhauser Effect Spectroscopy (NOESY), which first requires the determination of 
an optimum mixing time value (Tm) for each protein sample under investigation. The 
intensities of cross peaks at different Tm values were plotted for both the native and 
the MFI species in Figure 5.4. 
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Figure 5.4: Optimisation of mixing time for 2D NOESY experiment: The intensities 
of five off-diagonal peaks in the native (left panel) and the MFI (right panel) species are plotted 
for different values of the mixing times, Tm. Each cross-peak is identified with its chemical 
shift values in the first and second dimension, respectively: (81 ,82). Apart from Tm, all other 
conditions were kept constant in all experiments. For experimental details, see captions of 
Figures 5.5 and 5.6. 
The NOESY cross peaks for the native species get to their maximum intensity 
at rv220-250 ms of mixing time, so a safe value for Tm is 200 ms, to avoid contributions 
from spin diffusion. For the MFI species it was more tricky to define an optimum Tm 
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value, because the NOE cross peak intensities seem to vary irregularly with the Tm 
values. This may be because of the dynamic properties of this extremely non-rigid 
species. The 2D NOESY experiment for MFI was performed at various Tm values. 
However, most NOE's were observed at 200 ms, which is also the optimum value for 
the native species and hence the 2D NOESY spectra for the two species are compared 
at this Tm value. 
600 MHz NOESY spectra of the native and MFI states (Figures 5.5 and 5.6, 
respectively) show similar chemical shift dispersion, as noted for the lD spectra in 
Figure 5.1, and many NOE cross peaks. Compared to the native state, however, the 
MFI spectrum was much less well resolved, showing a large number of overlapping and 
broader resonances. This indicates the presence of slowly inter-converting conforma-
tions with different side chain environments. Rapid inter-conversion between major 
and minor conformations would tend to average chemical shift differences, and lead to 
weak NOEs. Given the poor spectral resolution resulting from multiple conformations, 
an atomic resolution structure determination was not feasible. 
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Figure 5.5: 600 MHz 2D 1 H NOESY of native AAI: the spectrum was acquired with 200 ms mixing time, spectral width 8000 Hz in both 
dimensions , 1024 complex points in direct and 512 complex points in indirect dimension. The data were zero-filled in the second dimension to 1024 
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Figure 5.6: 600 MHz 2D 1 H NOESY of MFI: the spectrum was acquired with 200 ms mixing time, spectral width 8000 Hz in both dimensions, 
1024 complex points in direct and 512 complex points in indirect dimension. The data were zero-filled in the second dimension to 1024 points. 
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5.5 Molecular dimensions of N and MFI 
In characterising non-native states of proteins in solution, a measurement of molecular 
dimensions is of considerable importance. A measure of average dimensions assumed 
by the conformational ensemble can provide information about the nature of structures 
adopted by the polypeptide chain [32]. It also has the importance in understanding 
the role of conformationally disordered states in protein folding, stability and aggrega-
tion. Mostly, molecular dimensions have been given in terms of measurements of the 
effective radius of gyration by small-angle scattering studies, using neutrons (SANS) or 
X-rays (SAXS). The alternative is to determine the hydrodynamic or Stokes radii with 
measurements of translational diffusion coefficients, using dynamic light scattering or 
pulsed field gradient NMR techniques [91, 154, 155], the last of which was used in the 
study of MFI. 
The molecular dimensions of N and MFI species were compared by performing 
NMR pulsed field gradient diffusion measurements. The approach focused on the es-
timation of the effective hydrodynamic radii of both species with a Pulsed Gradient 
Stimulated Echo Longitudinal Encode-Decode (PG-SLED) sequence [91, 156, 157]. In 
this experiment, the protein NMR signal decay, s, is measured as a function of gradient 
field strength, g, as indicated in Equation 5.1. The signal decay rate, d, is proportional 
to the diffusion coefficient, D, which is itself inversely proportional to the effective 
hydrodynamic radius, RH. By adding a small molecule, in our case dioxane, as an 
internal-radius standard [91, 154], absolute values for protein radii can be estimated as 
indicated in Equation 5.2. 
s A. e-dg2 (5.1) 
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Native 
d( dioxane): d(native) 
total average 
MFI 
d(dioxane): d(MFI) 
total average 
Rprotein 
H 
d(dioxane) 
7.75 
7.75 
7.77 
7.77 
7.78 
7.83 
5.77 ± 0.32 
d(dioxane) 
7.74 
7.89 
7.84 
7.91 
7.86 
7.92 
6.33 ± 0.41 
D dioxane Rdioxane 
. H 
Dprotein 
d( aliphatic) d(aromatic) 
1.35 1.26 
1.38 1.27 
1.45 1.29 
1.42 1.29 
1.29 1.23 
1.37 1.27 
5.66 ± 0.23 6.13 ± 0.11 
d( aliphatic) d(aromatic) 
1.13 1.14 
1.14 1.16 
1.30 1.19 
1.21 1.19 
1.33 1.24 
1.18 1.17 
6.47 ± 0.41 6.66 ± 0.18 
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(5.2) 
d(tyrosine H3,5) 
1.40 
1.39 
1.44 
1.45 
1.36 
1.41 
5.52 ± 0.13 
d(tyrosine H3,5) 
1.28 
1.35 
1.38 
1.31 
1.36 
1.35 
5.88 ± 0.14 
Table 5.1: NMR diffusion measurements: the table shows values for the signal decay rate, 
d, derived from the fitting of curves from NMR diffusion measurements. Each measurement 
was repeated six times and the result of each experiment is given in the table. Additionally, 
the first column for each species is filled with the values derived for the reference molecule: 
2,4-dioxane. At the bottom of each column the average ratio d(dioxane): d(MFI) is given and 
below the total average ratio for each species. 
The measurements with PG-SLED pulse sequence were completed by acquiring 
20 spectra and varying the strength of diffusion gradient between 100% and 5% of its 
maximum value. Each measurement was repeated six times to improve the signal-to-
noise ratio and allow the estimation of experimental error. The length of the diffusion 
gradient was optimised to give a total decay of protein signal between 80 and 90% 
at 100% gradient strength. Results are summarised in Table 5.1. The data for the 
diffusion coefficient, d, were obtained by integrating three regions of the NMR spectra 
from each species and fitting the resulting intensities to Equation 5.2. The regions 
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chosen for integration were a part of the aromatic region (6.70-7.70 ppm), a part of 
the aliphatic region (0.80-1.40 ppm) and a region of a tyrosine H(3,5) signal, which 
is well separated from other signals (7.00-7.08 ppm for the native species and 6.88-
6.93 ppm for MFI species). The decay rates have been extracted in each experiment 
also for the reference molecule, dioxane. The signal decay rate, d, is, as noted above, 
proportional to D, the diffusion coefficient, which is in turn inversely proportional to 
the effective hydrodynamic radius, RH. This is extracted from the Stokes-Einstein 
equation (Equation 5.3), where 'T/ is viscosity of the solvent. The ratio of RH values for 
the native and MFI species is given in Equation 5.4. 
D 
R N ·RMFI H· H 
kT 
6 7r RH 'T/ 
dMFI : dN = 0.91 ± 0.09 
(5.3) 
(5.4) 
Although absolute sizes of protein hydrodynamic radii must be interpreted with care [154], 
measurements of the relative sizes of similar species measured under similar conditions 
are much more robust. The ratio of effective hydrodynamic radii for the N and MFI 
species was 0.91 ± 0.09, and so the radii of the two species are indistinguishable within 
the experimental error. 
5.6 Molecular simulations of MFI structure 
A closer examination of the native AAI structure reveals that the six cysteine residues 
are near enough to each other that, in principle, all the 15 theoretically possible disulfide 
topologies can form via minor displacements of the main chain. 
A three-dimensional structure of MFI was modelled with the Biopolymer and 
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Discover modules of Insight!!. 10000 steps of the steepest descents method, followed 
by 1000 steps of the conjugate gradient technique were performed for energy mini-
mization. The final root-mean-square (rms) deviation was smaller than 0.001 A. Five 
random shakes of the starting atom coordinates resulted in identical final models. The 
root-mean-square-distances (rmsd) between the Ca atoms of the cysteine residues were 
calculated by optimal superposition of MFI's modelled structure with the native AAI. 
The average rms distance calculated for cysteine Ca atoms with respect to the 
native structure is 1. 72 A. The MFI model superimposed onto the experimental native 
structure is seen in Figure 5.7. It suggests a globular, compact structure resembling 
the native state. It should be emphasized that modelling of this sort shows that stereo-
chemically allowed structures with non-native disulfide bridges can be generated from 
the native tertiary scaffold of AAI protein, but not that these structures are necessarily 
observed. Energy minimization methods, which were used to generate the model are 
known to be unreliable at predicting loop structures. However, the region of the vicinal 
disulfide bridge in the model of MFI features a turn reminiscent of those found in the 
protein structures containing this feature (Chapter 4). 
Figure 5. 7: Molecular model of MFI: Stereo-view of the superposition of MFI species (blue) 
native AAI conformation (red). The N- and C-termini are denoted. The disulfide bonds are 
drawn in a dashed line. 
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5. 7 Conclusions 
Although it proved impossible to determine an atomic resolution structure of MFI, 
a consistent picture nevertheless emerges from the experiments. The structure is as 
compact as the native state, as indicated by the NMR diffusion measurements. There 
is little evidence from far-UV CD for secondary structure, but at least some of the side 
chains are ordered, as evidenced by the near-UV CD, the number of NOEs, the chemical 
shift dispersion and the large change in the chemical shift of the H(3,5) resonance of 
one of the tyrosine residues from its position in the native state. The additional lines 
visible in the NMR spectra, responsible for the poor resolution of the NOESY cross 
peaks, point strongly towards slowly inter-converting multiple conformations of the 
polypeptide backbone. Modelling suggests that the non-native disulfides in MFI do not 
constrain the backbone to the extent that native-like conformations of the backbone and 
native-like side chain interactions cannot exist. Nevertheless, the side chain exposures 
revealed by CIDNP and the differences in chemical shifts show that there are clear 
differences between the tertiary structures of the native and MFI states. 
Chapter 6 
Kinetic analysis of oxidative 
folding 
6.1 Introduction 
The study of kinetics of a folding process is essential for the understanding of the 
formation of the native structure. The kinetics of oxidative folding of AAI protein was 
studied to examine the stabilisation of the native disulfide bonds in vitro in different 
folding conditions. In addition, oxidative folding in vivo was mimicked with the addition 
of a protein disulfide isomerase. 
This chapter deals both with the kinetic process at the level of a single disulfide 
species and at the level of a single amino acid residue. Two different time-resolved 
techniques were used to follow the oxidative folding and their results were compared 
to examine the credibility of application of such techniques to oxidative folding. The 
kinetic data were analysed, fitted, plotted and the rate constants were calculated using 
Sigma Plot software. 
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6.2 Oxidative folding at the level of a single species 
The oxidative folding process of AAI was first studied on the level of a single disulfide 
species. The intermediate species, which take part in the folding process, were all 
previously characterised in terms of their disulfide content (see Chapter 4). They are 
covalently stable species, which are efficiently separated with an analytic RP-HPLC 
technique at acidic pH [ 41]. A time-resolved analysis of the transformation on the level 
of disulfide species was done in different folding conditions. 
6.2.1 Optimum oxidative folding conditions 
The first experiment was at the optimum oxidative folding conditions, where over >93% 
of the native protein is regenerated in 20 hours. The presence of disulfide species at 
different times after the start of folding was examined by removing aliquots from the 
folding mixture at selected time points and analysing them with RP-HPLC. Figure 6.1 
shows time-resolved chromatograms (A) and the abundances of disulfide species with 
respect to the folding time (B). It is clear from the chromatograms that the folding 
pathway is dominated by a few disulfide species, among which are especially prominent 
the five fully oxidised species with three disulfide bonds. 
The optimised oxidative folding of AAI is characterised by a high heterogeneity 
of one-, two- and three-disulfide species as discussed in detail before in Chapter 4. The 
rapid disappearance of the reduced species is fitted well to a 1st order exponential decay 
(R2 >0.99, where R is the multiple correlation coefficient) with a rate constant of 0.14 
min-1. The native species accumulates with a lower rate constant and is fitted well 
to a 1st order exponential rise curve with a rate constant of 0.0098 min-1. Non-native 
disulfide species (i.e. MFI, I-1, I-4, I-5, I-6) are present on the pathway of oxidative 
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folding. It may be that they play a specific role in directing the folding process through 
structural information that they contain. 
It is clear that the first non-native disulfide intermediate that accumulates is 
I-6, which is most abundant at about 5 minutes after the start of the folding. It 
is also the only fully oxidised intermediate on the folc;ling pathway, which contains a 
native disulfide bond (Cys8-Cys23). It could therefore be a close precursor of one-
and two-disulfide intermediate(s), which are in turn direct precursors of the native 
protein. Soon afterwards, at about 15 minutes after the start of folding, three other 
fully oxidised species (I-1, I-4 and I-5) reach their maximum abundance at almost the 
same time. The last three-disulfide intermediate to accumulate is MFI, which reaches 
its maximum abundance of almost 40% at 30 minutes. This means that reshuffling and 
isomerisation of non-native disulfides of this intermediate is a slow, rate-determining 
step in the process. 
6.2.2 · Oxidative folding in denaturing conditions 
The fully reduced AAI protein was refolded in the presence of different concentrations 
of guanidine hydrochloride (GdnHCl), which was used to disrupt the native structural 
preferences and interactions. The refolding reaction was monitored by time-resolved 
RP-HPLC. The chromatograms obtained from the folding mixtures 24 hours after the 
initiation of the folding reaction, containing from 0 to 6.0 M GdnHCl are compared 
in Figure 6.2. The reactions in the absence of GdnHCl and in its presence at 1.0 M 
concentration yield very similar results, reaching over 90% of native AAI product. As 
the concentration of GdnHCl is gradually increased to 6.0 M, the amount of native 
species, which is obtained after 24 hours of refolding, decreases rapidly and native 
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Figure 6.1: Oxidative folding at optimum conditions: lOOmg/1 AAI, 0.1 M NH4 0Ac, 2 
mM EDTA, 1.0 M GdnHCl, pH 8.50, lmM cysteine, 0.05 mM cystine, 25°C. A. Time-resolved 
chromatograms of the folding reaction, isolating all disulfide intermediate species, which appear 
on the pathway. Chromatographic profiles were obtained with a RP C18 analytic column (5 
µm) and a gradient of 0-20% B (5 min), followed by 20-273 B (30 min) at a flow rate of 0.8 ml 
min- 1 . B. The abundances of all fully oxidised species and the fully reduced protein are plotted 
versus the refolding time. Their abundances are taken from the intensities of the RP-HPLC 
peaks in A. and are calculated from their absorbance at 214 nm. 
AAI represents only 38% of all protein conformations at 6.0 M GdnHCl. At the same 
time, the other three-disulfide species (MFI, I-1, I-4, I-5 and I-6) are becoming more 
abundant, especially MFI, which reaches 32% at 6.0 M GdnHCl. This species is clearly 
favoured over the other three-disulfide species, whose abundances never reach more 
than 10% per single species. 
Denaturants are an important part of oxidative folding buffers, because they 
prevent aggregation and hence significantly increase the yield of the native protein. 
However, the concentration of denaturant is usually kept low (from 0 to 2 M urea 
or from 0 to 1 M GdnHCl) in order to balance aggregation and the formation of the 
native structural elements, such as the native disulfide bonds. In fact, the optimum 
refolding conditions for AAI oxidative folding involve 1.0 M GdnHCl in order to prevent 
aggregation and at the same time provide a high yield of the native conformation. 
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When the concentration of denaturant is increased, other disulfide connectivities might 
prevail or become significantly abundant. This is because in absence of a denaturant, 
secondary and tertiary preferences encoded in the amino acid sequence enable efficient 
conversion to the close packed native structure, which promotes the native disulfide 
pairing [25]. It is highly unlikely that a native 3D array of the backbone would allow 
two different disulfide pairings. At the same time, in small proteins such as AAI the 
native-like 3D conformations are not unlikely to be able to accommodate non-native 
disulfide bonds and non-native disulfide topologies. 
It has been confirmed in recent years that even proteins under highly denaturing 
conditions with reduced disulfide bonds keep a non-random structural preference for 
formation of secondary and tertiary structures [158]. Also, hydrophobic interactions 
persist under strongly denaturing conditions [159] and compact molten globule struc-
tures are present in the absence of disulfides [160]. A similar phenomenon is observed 
as the concentration of denaturant is increased in the oxidative folding of AAI. It does 
not lose the primary sequence's preference for the formation of the native structure and 
native disulfide bridges, which remains the most abundant conformation. 
At the same time, the probability of formation of disulfides in an unstructured 
chain decreases with the number of residues between the two cysteines [161]. There-
fore under conditions, where some secondary and tertiary interactions are disrupted, 
such as in the presence of a high concentration of a denaturant, the vicinal disulfides 
should exhibit the highest probability of formation. In the same way, the "bead-like" 
structures - in which disulphide bridges are formed from the cysteines nearest to each 
other within the sequence - have the highest probability of formation [48, 162]. Out of 
the three intermediates with a vicinal bridge, which would be favoured per se, the most 
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abundant, MFI, is indeed the one with the "bead-like" structure. It is also well known 
that single domain proteins featuring primarily sequence-local contacts (high "contact 
order") tend to fold with lower energy barriers than those characterized by more non-
local interactions (163). This is consistent with the accumulation of a significant amount 
of MFI. 
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Figure 6.2: Oxidative folding in the presence of guanidine hydrochloride: A. Time-
resolved RP-HPLC chromatograms are shown for the folding mixtures after 24h of oxidative 
folding. The oxidative folding conditions are kept constant (lOOmg/1 AAI, 0.1 M NH4 0Ac, 2 
mM EDTA, 1.0 M GdnHCl, pH 8.25, lmM cysteine, 0.05 mM cystine, 25°C), while GdnHCl 
concentration is varied from 0 to 6.0 M. The profiles were obtained with a RP C18 analytic 
column (5 µm) and a gradient of 0-203 B (5 min) followed by 20-303 B (30 min) at a flow 
rate of 0.8 ml min-1 . B. The abundances of the three-disulfide species after 24h of refolding 
are plotted versus the concentration of GdnHCl. 
6.2.3 Reductive unfolding from native and MFI species 
The mechanism of reductive unfolding of AAI protein was analysed. Purified native AAI 
protein was isolated and placed into a reducing buffer containing various concentrations 
of dithiothreitol (DTT) at pH 8.50. The unfolding experiments were quenched in a 
time course manner and analysed by RP-HPLC. The results show that the reduction 
of the native species leads to the direct conversion to the fully reduced species, without 
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accumulation of intermediate one-, two- or three-disulfide species. This phenomenon 
of a concurrent reduction is observed for different concentrations of the reducing agent, 
ranging from 5 to 100 mM. In Figure 6.3A, the time-resolved RP-HPLC chromatograms 
are shown for the reduction of native AAI with 5 mM DTT. The rate constant for 
the conversion of native to the reduced species (kN~R), which was extracted for four 
different DTT concentrations, shows a linear dependence upon the concentration of 
DTT, as seen in Figure 6.3C. The unfolding pathway was also examined with TCEP 
as a reducing agent (pH 3.0) and was found mechanistically unchanged. 
Because AAI either exists in the native three-disulfide topology or is reduc;ed di-
rectly to the reduced species, it follows the all-or-none reductive unfolding mechanism. 
This mechanism is shared also by other small cystine-rich proteins, such as hirudin, 
PCI and TAP [56]. The native disulfides of such proteins are stabilised in a concerted 
and interdependent manner, because they do not allow for intermediate species when 
the native disulfide bonds are reduced. Another important observation is that these 
proteins, which share a common reductive unfolding mechanism, also have the same 
characteristics in the oxidative folding pathway. AAI and the above mentioned pro-
teins all have a high heterogeneity of one-, two- and three-disulfide species, including 
non-native disulfide isomers. 
In contrast to the reductive unfolding of the native species, the mechanism of 
MFI for the same process was studied by LC-MS (Figure 6.4B) and it turned out to be 
very different. MFI forms two two-disulfide isomers and three one-disulfide isomers as 
intermediates during reductive unfolding (Figure 6.4B). The retention times of these 
isomers do not coincide with those of any other species on the oxidative folding pathway 
from reduced AAI, so they probably contain only MFI-disulfide bonds and are formed 
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Figure 6.3: Reductive unfolding pathway of native AAI: A. Time-resolved RP-HPLC 
profiles for reduction with 5 mM DTT at different times after the initiation. The reverse process 
of oxidative folding starts from purified native AAI species in the presence of a reducing agent, 
unfolds and gets reduced to form the fully reduced state (conditions: 0.5 mg/ml AAI, 0.1 M 
NH4 0Ac, pH 8.50, 25°C). B. Native AAI decay at different concentrations of DTT (5, 20, 50 
or 100 mM DTT) against reduction time. The decay is fitted to a 1st order exponential decay 
curve for each DTT concentration. C. The rate constants for native AAI decay (extracted from 
B.) plotted versus DTT concentration. 
when each MFI-disulfide is reduced in turn. This points to the fact that the disulfide 
bonds of MFI are not interdependent and are stabilised independently, probably be-
cause of the preference for forming disulfides between cysteines, which are closest to 
each other in sequence. 
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Figure 6.4: Oxidative folding and reductive unfolding from MFI: A. Oxidative fold-
ing starting from purified MFI species (100 mg/1 MFI, 0.1 M NH4 0Ac, 2 mM EDTA, 1.0 M 
GdnHCl, pH 8.50, 1 mM cysteine, 0.05 mM cystine, 25°C). Time-resolved RP-HPLC chro-
matograms of folding mixtures at different times after the start of oxidative folding. B. Re-
ductive unfolding of MFI (0.5 mg/ml MFI, 0.1 M NH4 0Ac, pH 3.0, 100 mM TCEP, 25°C) 
examined by LC-MS. The profile shows the mixture of products after 2 min reduction. The 
molecular masses of each species are shown, which determine their disulfide content. The pro-
files in both A. and B. were obtained with a RP C18 analytic column (5 µm) and a gradient of 
0-203 B (5 min) followed by 20-303 B (30 min) at a flow rate of 0.8 ml min-1 . 
6.2.4 Oxidative folding from a three-disulfide intermediate 
The folding pathway from purified MFI species was studied to examine the kinetic role 
of MFI on the oxidative folding pathway of AAI protein. MFI was purified from the 
refolding mixture after 30 min of the start of folding from reduced protein, when it is 
present in ""40% abundance. It was then re-inserted again into the oxidative folding 
buffer. The chromatograms obtained at different times of folding are shown in the 
Figure 6.4A. The rate constant for formation of native AAI is 0.0057 min-1, which is 
about half that found for folding from the reduced AAI protein at the same conditions 
(0.0095 min- 1 ). 
When MFI is isolated and inserted into the refolding buffer, its non-native disul-
fides are likely to be reduced independently. This is suggested by MFI's reductive 
unfolding mechanism, described in section 6.2.3 and seen in Figure 6.4B. A very sim-
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ilar folding pathway to the one proceeding from reduced AAI is observed in terms of 
the presence of disulfide species that are formed. All three-disulfide intermediates (I-1, 
I-4, I-5 and I-6) accumulate to significant amounts. If MFI's disulfides are reduced 
independently, I-5 and I-6 can form from the one-disulfide species, containing only the 
vicinal disulfide bridge. I-1 can similarly form from the one-disulfide isomer containing 
the Cys23-Cys31 bond, whereas I-4 can be made by partial reduction and isomerisation 
of disulfides in I-6. 
The reduced state was not detected, which could signify that MFI does not need 
to be completely reduced in order to start the folding process towards the native state. 
This affirms the independence of MFI's disulfide bonds. It has been noted previously 
that fully oxidised intermediates involving non-native disulfides do not need to unfold 
and be reduced entirely for conversion to the native structure [47]. It has to be noted 
however, that MFI is far from an immediate precursor of the native structure. The 
one- and two-disulfide species, which form from MFI, are either short lived, exist in a 
minute concentration or their conversion to other three-disulfide species is spontaneous 
and irreversible [47]. Even though the direct precursors of the native species are one-
and two-disulfide species with native disulfides, the rate-determining step of folding 
will be their formation from the three-disulfide isomers, such as MFI, as suggested 
previously in section 6.2.1. 
Species containing non-native disulfide bonds in oxidative folding that are sta-
bilised by non-native tertiary interactions are kinetic traps. Such species are off-
pathway intermediates, which have to overcome an energy barrier to unravel the struc-
ture they have already formed [53]. MFI is in this sense an off-pathway intermediate 
in the oxidative folding from reduced AAI to the native state. It has to undergo a 
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complex process of disulfide reshuffiing from non-native to native bonds, during which 
it forms other fully oxidised species (I-1, I-4, I-5 and I-6). 
6.2.5 Mimicking oxidative folding in vivo 
In vivo, the reduction and isomerisation of non-native disulfides made early in the 
oxidative folding process is essential to avoid misfolding. It is mostly achieved with 
the help of a folding catalyst, for example, protein disulfide isomerase (PDI), which 
catalyses the rearrangements that lead to native disulfides and native tertiary struc-
ture [164]. In an in vitro oxidative folding experiment the isomerisation can be induced 
with a reducing agent, which is frequently a core part of the refolding buffer. In the 
case of AAI this role is taken up by cysteine, which keeps a high reducing potential in 
order to convert non-native disulfides into reactive thiols. Disulfide isomerase proteins 
have been previously found in numerous other plant organisms, such as soybean [165], 
wheat [166, 167], maize [168] and rice [169]. It is therefore highly probable that Ama-
ranthus crop plants have a gene for a disulfide isomerase. In experiments with AAI, 
the bacterial homologue DsbC was used, whose 3D structure is known to contain two 
active sites for disulfide reduction and isomerisation [83]. 
In order to approximate the conditions of oxidative folding to those in the endo-
plasmic reticulum, AAI was refolded in the presence of DsbC enzyme. A time-resolved 
RP-HPLC study of oxidative folding in a buffer containing disulfide isomerase DsbC is 
seen in Figure 6.5. It can be seen that all three-disulfide species,' previously observed 
at optimum refolding conditions (MFI, I-1, I-4, I-5, I-6), are present on this pathway. 
However, MFI is not the most abundant intermediate species, but this is now I-1. The 
kinetics of native AAI regeneration was examined and compared to a study at the same 
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conditions in the absence of DsbC, seen in Figure 6.5B. Both kinetics fit well to a 1st 
order exponential growth curve (R2 >0.99) and have the following rate constants for 
the formation of native AAI protein: 0.014 min-1 with Dsbc, 0.0083 min-1 without 
DsbC. The final yield of the native AAI at this conditions is larger for the folding 
assisted by DsbC (94% versus 75% for the folding without DsbC). It has to be noted, 
however, that the high yield of formation of native AAI peptide in the presence of DsbC 
(94%) is comparable to the one obtained in the optimum refolding conditions (93%), 
described in section 6.2.1. The rate constant of formation of native AAI, is increased 
from 0.0095 min-1 in optimum refolding conditions (section 6.2.1) to 0.014 min-1 in 
the presence of DsbC (Figure 6.5B). 
AAI is a small protein with respect to the DsbC molecule, which is a homodimer 
containing over 400 amino acids residues. The efficiency of reduction and isomerisation 
of AAI's non-native disulfides depends on the accessibility of such disulfides to the 
DsbC active sites. Although these active sites are well exposed on the surface of DsbC 
protein (Figure 1.8), it might not be easy to access the "hidden" disulfides of a cystine 
knot. Structures with more solvent exposed disulfides are probably isomerised more 
efficiently than others. This last observation could be an explanation for the fact that 
MFI is not as abundant in the folding assisted by DsbC, because a "bead-like" disulfide 
pattern probably has a high disulfide accessibility. The energy barrier for conversion 
of MFI to one- and two-disulfide species could be lowered in this way. 
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Figure 6.5: DsbC assisted oxidative folding: A. Time-resolved RP-HPLC profiles of DsbC assisted oxidative folding of AAI protein (lOOmg/1 
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6.3 Oxidative folding at the level of a single residue 
In order to follow the conformational changes that accompany the oxidative folding 
process on the level of a single amino acid residue, a series of experiments using lD 1 H 
NMR and photo-CIDNP spectroscopy was carried out. As before for the study at the 
level of a single disulfide species, the properties of the known equilibrium species, which 
appear on the folding pathway were elucidated. In the case of NMR and photo-CID NP 
study, the lD spectra of the three milestone species of the oxidative folding reaction 
were compared to the time-resolved spectra obtained from the folding mixture. 
6.3.1 Time-resolved NMR study 
The tertiary folds of the three milestones of the folding pathway of AAI were first eluci-
dated with equilibrium NMR. Purified reduced (R), MFI and native (N) samples were 
used in order to obtain orientation spectra for the conformational arrangements along 
the folding pathway (right panels in Figures 6.6 and 6. 7. Chemical shift assignments of 
the native state were taken from Lu et al [20], assignments for the aromatic region as 
well as some assignments in the aliphatic region of MFI were obtained previously from 
lD photo-CIDNP and 2D COSY experiments (see Chapter 5). Some reduced species 
assignments were obtained from lD photo-CIDNP. The spectra of R show a series of 
fairly well resolved lines corresponding to the resonances of the component amino-acid 
residues in similar environments. However, this species does not display a completely 
random coil conformation, a fact that has been noted previously also for highly de-
natured proteins [170]. The corresponding spectra of the N state include significant 
dispersion in chemical shifts, a typical characteristic of native tertiary folds with per-
sistent tertiary features. The NMR spectrum of the purified MFI species resembles that 
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of the N state as the chemical shifts are well dispersed and the lines are narrow, but 
the spectrum of MFI shows additional weaker signals, owing to minor conformation(s) 
present aside from the main conformation. 
The equilibrium spectra of these three species were compared with the time-
resolved spectra in order to look for the characteristics of the conformational folding 
assembly at different times of the refolding reaction. For the time-resolved experiments 
the protein conformations were separated from the refolding buffer with RP-HPLC, 
also to render the aliquots more stable while acquiring the NMR data. The NMR 
experiments were done on aliquots of protein assemblies from the folding reaction, 
which was stopped at different times after the initiation. 
The aromatic region of the NMR spectra is shown in Figure 6.6. Here the NMR 
signals of four aromatic residues (Tyr21, Tyr27, Tyr28, Trp5) are shown for the equi-
librium species and the time-resolved samples. There are several examples of how a 
peak with a native chemical shift develops through the folding reaction, for example 
of Tyr27(H2,H6) and Trp(H7), which are distinguishable already after 45 and 90 min 
of the folding reaction, respectively. The peaks belonging to MFI conformation appear 
almost immediately after the start of the reaction (15min) and slowly, but not com-
pletely, disappear from the folding assembly. Even after 1200 min, there is some MFI 
present in the mixture and the best-resolved example of an MFI peak is TyrC(H3,H5). 
The aliphatic region of 1 H NMR (Figure 6. 7) shows a similar picture, although there 
are fewer lines as well resolved and as representative of the three equilibrium species. 
Three native resonances are partially restored as early as 45 min after the initiation 
of the folding reaction: Thr22(H12), Va115(H1l) and Val15(H12). The chemical shifts 
of the signals for MFI and the reduced species in this region are almost entirely over-
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lapping, so one cannot say with certainty much about the disappearance of reduced 
state and the appearance of MFI. The only peak which is distinguishably non-native is 
Thr22(ff"y2), but even here MFI and reduced states overlap. 
It has to be noted however, that some intensity in the NMR peaks, which are 
thought to belong to a specific species, for example MFI, could also be partially con-
tributed from other disulfide intermediates with similar structural features. Therefore, 
peaks could be looked at as representatives of a specific structural environment for the 
residue in question. 
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Figure 6.6: 600 MHz ID 1 H spectra of oxidative folding of AAI, aromatic region: Samples for the equilibrium spectra were purified on 
analytic RP-HPLC , lyophilised and re-dissolved at 1.0 mM in D20 at pH 7.0. Samples for the time-resolved spectra were prepared in the following way. 
Purified reduced AAI was dissolved in the refolding buffer (lOOmg/1 AAI, 0.1 M NH4 0Ac, 2 mM EDTA, 1.0 M GdnHCl, pH 8.50, 1 mM cysteine, 0.05 
mM cystine, 25°C). 10.0 ml aliquots were quenched at with 4 3 TFA at various refolding times. The protein content of these aliquots was separated 
from the refolding buffer with RP-HPLC (gradient: 0-603 B in 10 min). Samples were then lyophilised and kept under N2 at 4°C before they were 
re-dissolved in D20 at pH 7.0. Sample stability was confirmed by comparing analytical RP-HPLC profiles before lyophilisation and after the NMR 
experiment. Spectra were recorded at 25°C, pH 7.0, with 10000 Hz spectral width, 4096 complex points and 512 acquisitions. 
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6.3.2 Time-resolved photo-CIDNP study 
The photo-CIDNP experiments monitor not only the restoration of the native state 
and the abundance of various intermediates at different times, but also the accessibility 
of the four aromatic residues during the oxidative folding process. In this experiment 
the NMR signal intensity can be diminished by several factors, but primarily by the 
presence of the cysteine thiol groups. 
First, preliminary experiments were done on all principal components of the 
folding buffer to test them for quenching effects of the FMN dye polarisation in the 
photo-CIDNP reaction. Cysteine, which is a present at 1.0 mM concentration, was 
found to have a strong quenching effect on the triplet state of FMN, which is responsible 
for polarization transfer and signal enhancement of the aromatic side chains of amino 
acid residues. This quenching phenomenon was assigned to its thiol group, well known 
to be an FMN triplet quencher, without production of CIDNP [113]. The oxidative 
folding buffer contains several other components at reasonably high concentrations (i.e. 
0.1 M NH40Ac, 1.0 M GdnHCl) with respect to the total protein concentration and 
the photo-sensitiser dye. This is why non-protein components of the refolding buffer 
were removed as described in the caption to Figure 6.6. 
In the equilibrium photo-CIDNP spectra (Figure 6.8) of the three milestone 
species the four aromatic residues (Tyr21, Tyr27, Tyr28 and 'frp5) participate in giving 
the signals. In the photo-CIDNP spectrum of the N species Tyr27 and Tyr28 are very 
well accessible, but Tyr21 seems less accessible. MFI shows accessibility for all three 
tyrosine residues, both in its major and minor conformation(s). This was discussed in 
detail in Chapter 5. The spectrum of the reduced species is similar to that of MFI and 
although this spectrum has not been assigned entirely, we can expect that the signals 
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appearing are from all four aromatic side chains. The signal intensity of this spectrum 
is somewhat hampered by the presence of the six thiol groups. 
The time-resolved photo-CIDNP spectra can again be analysed in terms of the 
appearances of native, MFI and reduced resonances. The reduced peaks disappear 
within 30 min of the initiation of the folding reaction and this is especially clear for 
the Trp5(H4) peak, which is not overlapping with its native and MFI equivalents. The 
MFI peaks overlap both with the peaks of N and R. However, the emissive peaks of the 
(H3,H5) protons of TyrC and TyrA residues are well separated. They appear soon after 
the start of the folding and have significant abundance up to 150 min of refolding. The 
restoration of the native state is confirmed with Trp5 and Tyr27,28(H3,H5) resonances. 
It can be seen that from 45 min onwards there is some accumulation of the native state, 
which prevails from about 120 min of folding onwards. 
One interesting observation is the disappearance of the number of peaks and 
their intensities in the region between 6. 7 and 6.9 ppm of the time-resolved photo-
CIDNP spectra with time. In this region of AAI spectrum, the resonances belonging to 
Tyr(H3,H5) protons appear as emissive peaks. At the beginning of oxidative folding, 
there is a large number of emissive peaks, which represents the large number of confor-
mations where Tyr(H3,H5) protons are accessible. The intensities of some of this peaks 
gradually decrease and eventually some disappear. As the folding proceeds, one main 
peak is appearing (belonging to native Tyr27,28) and its intensity is growing. This pro-
cess of disappearance of the emissive peaks qualitatively represents the disappearance 
of the number of conformations and Tyr residues, where the side chains are accessible 
to the solvent. Indirectly, this phenomenon could also be seen as the funnelling of a big 
number of conformations towards a more compact, native tertiary scaffold with fewer 
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and less accessible side chains. 
In the above time-resolved 1 H NMR experiments, the signal intensities were di-
rectly proportional to the percentage population of an equilibrium species, but here 
there are many more factors, which can influence the signal intensity. In the equilib-
rium spectrum of the reduced species the signal-to-noise ratio is substantially lowered 
because this species possesses 6 thiol groups, which may all quench the triplet state of 
FMN. The accessibility of different aromatic residues changes as disulfide bonds are be-
ing oxidized and reshuffled to the three native disulfide bridges. It seems as though the 
tryptophan signals are higher than tyrosine in the spectra of MFI and reduced species. 
This could mean that Trp5 residue is relatively more accessible in these two species 
than in the native species, where its signals are comparable to those of the tyrosine 
residues. However, care must be take with such interpretation, because both types of 
amino acids compete for the triplet flavin and the reaction rate constant is higher for 
Trp than for Tyr [171]. 
7'.6 7'.4 7~2 1:0 6.o ppm 
W5(H4 
y 28(H2,H6) 
W5(H2)/ 
W5(Hf\~)A / Y27 
W5(H7) _;vv ~HZ,H6) native 
MFI 
YA 
(H3,H5) 
reduced 
71.6 7.4 7.2 i.o 6.8 6'.6 ppm 
Figure 6.8: 600 MHz ID 1 H photo-CID NP spectra of oxidative folding, aromatic region: Samples for the equilibrium and the time-resolved 
spectra were prepared as described in caption to Figure 6.6. Flavin mononucleotide (FMN) was added at 0.2 mM concentration. Spectra were recorded 
at 1.0 mM AAI, 25°C, pH 7, with 10,000 Hz spectral width, 4096 complex points and 16 acquisitions. 
~ 
~ 
0 
>< s: 
~ <. 
Cl) 
~ 
s: 
s· 
C1Cl 
~ 
e+-
t:i' 
Cl) 
-Cl) 
~ 
-0 
~ 
ll' 
rJJ 
s· 
C1Cl 
-Cl) 
"1 
Cl) 
rJJ 
s: 
c:: 
Cl) 
~ 
~ 
~ 
6.3. Oxidative folding at the level of a single residue 120 
6.3.3 Comparison between single species and single residue studies 
This is the first time that time-resolved NMR and photo-CIDNP studies are used to 
analyse a complete oxidative folding pathway. This is why it is important that the 
interpretation of results from the application of these techniques are examined for their 
credibility. These results from single-residue techniques are compared to the results 
from the single-species HPLC techniques (Figure 6.9). 
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Figure 6.9: Comparison of NMR and HPLC study: The data for the formation of native 
AAI species are compared for the NMR and RP-HPLC study. The rate constants are extracted 
from the 1st order exponential curves, which are fitted to the data. 
The rate constants calculated for the three curves seen in Figure 6.9 are of the 
same order. The RP-HPLC study curve has a rate constant of 0.010 min- 1, the aro-
matic NMR data 0.0080 min- 1 and the aliphatic NMR data 0.0064 min- 1. This in-
dicates that time-resolved NMR experiments of this kind are a valuable technique for 
the study of conformational developments on an oxidative folding pathway. Photo-
CIDNP intensities can not be used in quantitative comparisons of data, because they 
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do not only reflect the abundances of different species. An example for qualitative 
interpretation of the data in give in section 6.3.2. 
6.4 Conclusions 
The kinetics of oxidative folding was studied at the levels of a single species and a single 
residue. At the level of a single disulfide species, the kinetics in different conditions 
and the rate constants of formation of native AAI were compared. The configuration 
of the energy landscape was found to be independent of the rate of formation of the 
native AAI protein, which depends on the conditions of the folding buffer. This fact 
·has been previously observed for other oxidative folding pathways [55]. 
MFI is statistically the most probable disulfide conformation when reduced AAI 
protein is allowed to refold. In the presence of high concentrations of denaturant 
that weakens the secondary and tertiary interactions, which usually drive the folding 
process, MFI was the most abundant conformation apart from the native state. The 
examination of the reductive unfolding mechanisms for the native and MFI species 
revealed the interdependence of disulfide bonds in a cystine knot arrangement of the 
former and their independence in a "bead-like" arrangement of the latter species. This 
defines MFI as an off-pathway species of the oxidative folding pathway, because it needs 
to reduce its disulfide bonds in order to proceed with the search for the native pairing. 
Oxidative folding was also examined in the presence of a protein disulfide isomerase, 
DsbC. All three-disulfide species observed before in optimum refolding conditions were 
present on the pathway assisted by this enzyme and MFI was not the most abundant 
one. 
The study of AAI oxidative folding at the level of a single amino acid residue 
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was done with time-resolved NMR and photo-CIDNP spectroscopies and this is the first 
time that the latter technique is applied to this kind of process. Both techniques proved 
to be valuable for the study of conformational developments and aromatic accessibility 
changes along oxidative folding pathways. The data obtained for rate constants of 
native AAI formation were successfully compared with the data from single-species 
RP-HPLC studies. 
The high statistical probability of formation of a "bead-like" disulfide pattern 
may well be responsible for the accumulation of MFI in the early stages of oxidative 
folding. It is difficult to say whether it is the structural constraints imposed by the 
non-native disulfides or the prefererices encoded in the primary sequence that can be 
considered more important in directing the oxidative folding process by creating a 
compact fold. Non-native interactions in protein folding have been suggested to play a 
potentially significant role even for small proteins with- simple topologies [172]. In the 
same way, the non-native disulfides on AAI's oxidative folding pathway could have a role 
in directing the folding process. More importantly, the native-like tertiary interactions, 
which have to be on average more stabilising than the non-native ones, will bias the 
system towards the native state, which will favour also the native-like disulfide pairing. 
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